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ABSTRACT
Premature birth has risen steadily over the last decade resulting in an increased
number of infants needing neonatal intensive care. The demand for neonatal intensive
care has lead to many improvements in the delivery of such care with an increase in the
survival of the smallest and most premature infants. However, most of these infants are
being discharged from neonatal intensive care units (NICU) with severe extrauterine
growth restriction (EUGR).
Extremely low birth weight (ELBW) infants born at 23-27 weeks gestation and
who have a weight of less than 1,000 grams are at the highest risk for EUGR because of
their low birth weight and extreme prematurity. The need for prolonged mechanical
ventilation and blood pressure support delays the ELBW infant from receiving needed
amounts of early nutrition during the first few weeks of life. This lack of early nutrition
leads to large and ongoing energy and protein deficits, which have been cited as the
leading cause of EUGR in the ELBW infant. Despite current evidence that supports the
administration of early aggressive nutrition in the ELBW infant to improve extrauterine
growth, clinical practice remains largely unchanged.
The Institute of Medicine (IOM) in its 2008 report states that the use of evidenced
based clinical practice guidelines (CPG) has the potential to reduce undesirable practice
variation thereby eliminating the use of ineffective interventions. Developing evidenced
based CPGs utilizing a systematic, rigorous and transparent process will serve to
standardize practice while improving clinical outcomes. Therefore, the purpose of this
doctoral project is to provide an evidence based CPG on the nutritional management of
the ELBW infant. The CPG includes evidence based recommendations that are centered
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on promoting adequate extrauterine growth during the NICU stay in order to prevent
EUGR in the ELBW infant.
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NUTRITIONAL MANAGEMENT OF THE EXTREMELY LOW
BIRTHWEIGHT INFANT: AN EVIDENCE BASED
CLINICAL PRACTICE GUIDELINE
CHAPTER 1
BACKGROUND, PROBLEM and PURPOSE
Premature birth has risen steadily over the last decade resulting in an increased
number of infants needing neonatal intensive care. The demand for neonatal intensive
care has lead to many improvements in the delivery of such care with an increase in the
survival of the smallest and most premature infants. However, most of these infants are
being discharged from neonatal intensive care units (NICU) with severe extrauterine
growth restriction (EUGR) putting them at risk for poor neurodevelopment and severe
handicaps later in life (Hans, Phylipow, Long, Thureen & Georgieff, 2009; Kashyap,
2007; Martin, et al., 2009; Stephens, et al., 2009; Vlaardingerbroek, van Goudoever &
van den Akker, 2009).
EUGR occurs when a premature infant’s growth falls below the 10th percentile of
that for a normal fetus at the same gestational age (Clark, et al., 2003; Coverston &
Schwartz, 2005; Yu, 2005). The infants at highest risk for developing EUGR are those
classified as extremely low birth weight (ELBW). ELBW infants born at 23-27 weeks
gestation and who have a weight of less than 1,000 grams are at high risk for EUGR
because of their low birth weight and extreme prematurity.
The extreme prematurity of the ELBW infant’s organs and organ systems limits
their ability for transition to extrauterine life. Many ELBW infants require prolonged
mechanical ventilation due to their immature lungs, blood pressure support due to their
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immature myocardium, and parenteral nutrition due to their immature gastrointestinal
system (Gleason & Devaskar, 2012). The need for such support delays the ELBW infant
from receiving needed amounts of early nutrition during the first few weeks of life
resulting in poor growth (Stephens et al., 2009).
In utero, the ELBW infant would be receiving twice the amount of amino acids
needed for protein accretion with the excess amount being oxidized for energy production
(Adamkin, 2005). Glucose would be delivered at a rate that meets fetal energy
expenditure and would be controlled by maternal glucose concentration (Clark et al.,
2003). Lipid uptake would be minimal and be done at a rate that meets the essential needs
for neuron development (Hay, 2006)
In contrast, during the first weeks of extrauterine life amino acids are withheld or
given in minimal amounts due to concern for the ELBW infant’s ability to catabolize
early amino acids (Adamkin, 2005; Hay, 2006). Glucose is given as the sole source of
energy resulting in concentrations that are too high for the ELBW infant, leading to
hyperglycemia (Hay, 2006). Intralipids are held due to hyperglycemia and the risks of
lung injury and kernicterus (Clark, et al., 2003).
Postnatal nutrition regimens utilizing glucose as the sole energy source and
lacking adequate amounts of protein result in large protein and energy deficits in the
ELBW infant. These deficits may reach up to 300kcal/kg and 12g/kg of protein within
the first week of life leading to altered growth at the cellular and systemic level (Clark et
al., 2003). The cumulative and ongoing deficits of energy and protein are cited as the
leading cause of EUGR in the ELBW infant (Adamkin, 2005; Clark et al., 2003;
Coverston & Schwartz, 2005; Ehrenkranz, 2007; Hay, 2006).
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Extensive research has been conducted to determine the best nutritional regimen
for preventing EUGR in the ELBW infant. Data from randomized controlled trials (RCT)
strongly suggests providing nutrition that mimics the intrauterine environment may
improve energy intake and prevent protein loss, thereby improving growth in the ELBW
infant (Ibrahim, Jerondi, Baier, Dhanireddy & Krouskop, 2004; Wilson, et al., 1997).
Despite these data providing strong evidence for improving EUGR, clinical practice
remains largely unchanged.
Bloom et al. (2003) found a wide variation in postnatal weight gain among 51
NICUs within a healthcare network leading them to conduct a quality improvement
project. Upon further review of each NICU, it was noted that systems of care and
standards of practice varied based on healthcare provider habit or history of the unit.
Hans et al (2009) believe this type of practice is due to a lack of knowledge, systematic
planning and practice implementation. Whereas, Ehrenkranz (2007) & Martin et al.
(2009) believe this type of practice is due to the lack of evidence based CPGs. Therefore,
the purpose of this doctoral project is to provide an evidence based CPG on the
nutritional management of the ELBW infant.
The aim of this CPG is to guide clinical practice in the nutritional management of
the ELBW infant from birth to hospital discharge. The evidence based recommendations
address fluid and electrolyte management, energy and mineral intake, glucose
administration, early aggressive nutrition, enteral feedings, and nutritional assessment.
These recommendations are centered on promoting adequate extrauterine growth of the
ELBW infant in order to prevent or at least decrease EUGR.

3

CHAPTER 2
REVIEW OF THE LITERATURE
This chapter is presented in three parts. Part I presents an overview of evidence
based practice (EBP), Clinical practice guidelines (CPG) and CPG development,
formulation of clinical questions, systematic reviews, and evidence grading. Part II
presents an overview of clinical situations that must be considered in the nutritional
management of the ELBW infant. Part III provides evidence tables developed from a
review of the literature detailing the supportive data for this doctoral project.
The review of the literature was completed using Pubmed, The Cochrane Database of
Systematic Reviews, and Cumulative Index to Nursing and Allied Health Literature
(CINAHL) electronic databases. The literature search was restricted to include articles in
the English language but no restrictions were placed on publication date or type of
research study. Search terms included laboratory assessment, nutritional assessment,
growth and growth assessment, premature infant, low birth weight infant, very low birth
weight infant, and extremely low birth weight infant.
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PART I: OVERVIEW
EVIDENCE BASED PRACTICE
In Crossing the Quality Chasm: A New Health System for the 21st Century, the
Institute of Medicine (IOM) (2001) points out that the U.S. healthcare system lacks
sufficient design to promote quality care due to an abundance of research not being
translated into practice within a timely manner. This report is credited with highlighting
the need for EBP, which is a problem solving approach that integrates the best evidence
from systematic research with clinical expertise and patient values to make clinical care
decisions (Fineout-Overholt, Levin & Melnyk, 2004; Mateo & Kirchhoff, 2009;
Newhouse, Dearholt, Poe, Pugh & White, 2007). Generally, EBP is considered a process
that includes: asking a clinical question in the PICO format, utilizing systematic reviews
to evaluate and summarize the evidence, translating the evidence into CPGs and
evaluating the outcomes (Fineout-Overholt, et al., 2004) The aim of EBP is to decrease
variation in clinical practice that utilizes the best evidence to improve clinical care
processes and outcomes.
CLINICAL PRACTICE GUIDELINES
A CPG is a set of systematically developed statements designed to guide
clinicians and patients in their decisions about the appropriate health care for specific
clinical conditions (IOM, 2008). The recommendations included in a CPG should be
linked to the scientific research that supports them which is identified through a rigorous
process of systematic review and appraisal of the literature (Hargrove, Griffer & Lund,
2008; Melnyk, 2004; Poolman, Verheyen, Kerkhoffs, Bhandari & Schunemann, 2009;
Turner, Misso, Harris & Green, 2008).Moreover, CPGs developed utilizing the evidence

5

obtained from systematic reviews may serve as key resources to translate the evidence for
clinical practice, thus decreasing ineffective variation in practice and improving clinical
outcomes.
CLINICAL PRACTICE GUIDELINE DEVELOPMENT PROCESS
The purpose of a CPG is to give clinicians and patients statements regarding the
best evidence for making clinical health care decisions. However, many CPGs are being
developed by national agencies and special interest groups leading to a decentralized
process for CPG development creating bias and inherent problems with the final product
(Bondmass, 2009; Clutter, 2009). In 2008, the IOM published Knowing What Works in
Health Care: A Roadmap for the Nation, which called attention to the lack of
standardization in the process for developing a CPG.
In 2008, the IOM recommended that clinical recommendations in CPGs be
developed by a panel of experts who are knowledgeable of the clinical problem and are
capable of understanding the relevant research in order to make a sound judgment. The
process should also include two separate grading systems; one to grade the quality of
evidence and one to grade the strength of evidence. Furthermore, the IOM (2008) pointed
out that using a standardized transparent and scientifically rigorous process would result
in trusted CPGs that would discourage undesirable practice variation while encouraging
the use of interventions that are known to be effective.
CLINICAL QUESTION
The first step in developing a CPG is asking a clinical question, which needs to be
as specific as possible, since it will drive the strategies used to search the evidence
(Newhouse et al., 2007). The PICO format is most commonly used to narrow the clinical
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question and clearly identify the problem and key words that may be used for searching
the evidence. PICO stands for P patient I intervention C comparison with another
intervention and O outcomes. Asking clinical questions in this format allows one to
conduct a comprehensive literature review in a systematic way to identify clinical
research studies that truly answer the question.
SYSTEMATIC REVIEW
Systematic reviews are a summary of the research evidence in evaluating clinical
interventions intended to treat and/or prevent disease (Stevens, 2008). The systematic
review process includes retrieving, critically appraising and synthesizing randomized
controlled trials to answer a clinical question (Melnyk, 2004). According to the IOM
(2008) conducting systematic reviews delineates what is known and not known about the
effectiveness of a health intervention. Systematic reviews are considered to be the
strongest level of evidence, which should be used when making clinical decisions.
GRADE SYSTEM
The GRADE (Grades of Recommendation, Assessment, Development and
Evaluation) System provides a comprehensive, precise and transparent method for
grading the quality of evidence and the strength of recommendations included in CPGs
(Brozek et al., 2009; Guyatt, 2011). GRADE categorizes evidence as high, moderate, low
and very low depending on a study’s methodology, consistency, precision and directness.
The strength of a recommendation is categorized as strong or weak depending on the
desirable effects of the intervention.
The GRADE system provides a simple and transparent but rigorous approach to
grading the quality of evidence and the strength of recommendations when developing
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CPGs. The use of such a simplistic and transparent system to develop CPGs not only
meets the IOM’s recommendations but the use of GRADE makes it easier for patients
and their healthcare providers to interpret recommendations in a CPG when making
clinical care decisions (Guyatt, 2008).
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Part II: THE EXTREMELY LOW BIRTHWEIGHT INFANT
The ELBW infant is usually born during the last part of the second trimester or
the early part of the third trimester (23-27 weeks gestation). The second and third
trimesters of pregnancy are characterized as a time in gestation when increased growth
and development of the fetus is occurring (Gleason & Devaskar, 2012). An infant born
during this time in gestation has underdeveloped organs and organ systems. The
immaturity of the ELBW infant and the limited ability of their organ systems to regulate
body function pose unique clinical situations that must be considered when caring for
such infants (Lee & Jain, 2000).
Fluid & Electrolyte Balance
The ELBW infant has a large amount of total body water due to a lack of fat
tissue and a larger amount of lean body mass. At 24 weeks gestation, the fetus is
estimated to have a total body water content of 90%, which is mostly contained in the
extracellular space (Fusch & Jochum, 2005). This amount of fluid in the extracellular
space results in a larger fluid load for the ELBW infant’s immature kidneys to excrete
during postnatal diuresis.
Postnatal diuresis occurs in three phases: the pre-diuretic phase, diuretic phase,
and post-diuretic phase. The pre-diuretic phase occurs during the first 24-48 hours of life
and is characterized by low urine output due to a fall in glomerular filtration rates (GFR)
(Lee & Jain, 2000). Oliguria during the pre-diuretic phase is usually prolonged in the
ELBW infant due to a lower fractional excretion of sodium (FENa) and the presence of
respiratory distress (Fusch & Jochum, 2005). As respiratory distress resolves and FENa
improves urine output starts to increase and is followed by the diuretic phase, which may
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last 2-4 days. The diuretic phase is marked by high urine output and insensible water loss
due to extracellular fluid volume contraction (Lee & Jain, 2000). During the diuretic
phase, the ELBW infant is at high risk for fluid and electrolyte imbalances due to the
large amount of insensible water loss (IWL) via the immature epidermal skin layer ,
which is estimated to be as high as 5-7ml/kg/day (Baumgart, 2008; Fusch & Jochum,
2005).
Fluid and electrolyte balance during the diuretic phase of postnatal diuresis is
critical in the ELBW infant. Failure to replace IWL will result in dehydration and
hypernatremia whereas failure to administer adequate sodium at a time of high FENa
results in hyponatremia (Bhatia, 2006). Potassium balance is also affected by the amount
of IWL and the ELBW infant may experience non-oliguric hyperkalemia that occurs
when intracellular potassium shifts out of the cell due to the contraction of the
extracellular fluid compartment (Baumgart, 2008). The increased level of extracellular
potassium coupled with the ELBW infant’s diminished capability of excreting potassium
during the diuretic phase of postnatal diuresis leads to further elevation of potassium
levels and the possibility of cardiac arrhythmias (Lee & Jain, 2000).
The post diuretic phase of postnatal diuresis usually occurs within 1-2 weeks of
life when urine output normalizes and the infant reaches a steady state of fluid balance
(Fusch & Jochum, 2005). This phase marks the completion of extracellular fluid volume
contraction, a decrease in total body water, and an increase in cell mass (Lee & Jain,
2000). Postnatal diuresis results in a large amount of fluid loss and postnatal weight loss
for the ELBW infant. Although weight loss is expected during postnatal diuresis the
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ELBW infant loses 5-10% more of their birth weight than preterm infants born at higher
gestational ages (Fusch & Jochum, 2005).
Energy Requirements
The ELBW infant has a large body surface area relative to body mass and is
poorly insulated due to their thin skin and lack of subcutaneous fat stores leading to rapid
heat loss and the need for increased energy to maintain a normal body temperature (Lee
& Jain, 2000). IWL during postnatal diuresis further increases the energy needed for the
ELBW infant to maintain their own temperature (Hay, 1994). Although placing ELBW
infants in heated and humidified double walled isolettes improves thermoregulation their
energy requirements to promote growth an adequate weight are higher than the average
growing premature infant (Carr, Denne & Leitch, 2000).
Glucose Management
Glucose is the predominant source of energy provided to the ELBW infant
postnatally. In-utero, glucose is delivered via the placenta at a rate that meets fetal
energy needs and is dependent on maternal glucose concentrations with glycogen stores
increasing throughout gestation (Clark et al., 2003). Birth of the ELBW infant results in
minimal to no glycogen stores and poor glucose synthesis due to immature enzymes
responsible for gluconeogenesis (Thureen & Hay, 2008). Decreased glycogen stores and
inadequate glucose synthesis place the ELBW infant at high risk for hypoglycemia
especially when faced with the stress from hypothermia, respiratory distress, and possible
sepsis (Lee & Jain, 2000).
The ELBW infant’s risk of hypoglycemia and high energy needs leads the
clinician to administer high rates of glucose. The inability of the ELBW infant to regulate

11

insulin production and glucose synthesis due to stress results in glucose intolerance and
hyperglycemia (Hay, 1994). Hyperglycemia in the ELBW infant leads to a hyperosmolar
state, osmotic diuresis and further fluid and electrolyte imbalances (Lee & Jain, 2000).
Respiratory Complications
Managing early fluid and electrolyte imbalances in the ELBW infant can be quite
difficult especially when the treatment for respiratory distress syndrome (RDS) and
patent ductus arteriosus (PDA) involves restricting fluid intake for a period of time
(Baumgart, 2008). RDS is a lung disease seen only in premature infants due to a lack of
surfactant production. Surfactant is a phospholipid produced by type II pneumocytes,
which are first seen at 24 weeks gestation and mark the beginning of saccular
development of the lungs (Jobe, 2008) The saccular phase of lung development is when
gas exchange begins to occur and defines the viability of an ELBW infant (Rutter & Post,
2008).The lack of surfactant in the ELBW infant adversely affects pulmonary function
due to an increase in atelectasis, poor pulmonary compliance and necrosis of epithelial
tissue in the lungs (Lee & Jain, 2000). Synthetic surfactant does exist and rapidly
improves pulmonary function once it is given. But, positive pressure and mechanical
ventilation are still needed to support the ELBW infant.
Prolonged mechanical ventilation with positive pressure results in remodeling of
the ELBW infant’s lung tissue (Rutter & Post, 2008). Positive pressure destroys epithelial
tissue in the lung causing pulmonary edema from leakage of protein and extravascular
fluid into the terminal conducting airways (Lee & Jain, 2000). Continued exposure to
positive pressure ventilation promotes further destruction to lung tissue resulting in
chronic lung changes and the development of bronchopulmonary dysplasia (BPD).

12

BPD is the need for oxygen at 36 weeks postconceptual age (PCA) along with
chest x-ray findings of pulmonary fibrosis and emphysematous changes (Walsh, 2008).
The cause of BPD is multi-factorial and is the result of immature lungs damaged by
mechanical ventilation and oxygen toxicity resulting in inflammation and cellular injury
from oxygen radicals (Belik, 2008; Oh et al., 2005). Inflammation and cellular injury
increase the need for ventilation causing a continual cycle of inflammation, cellular
injury and pulmonary edema.
Developing BPD can be prevented if appropriate management strategies of RDS
are utilized within the first few weeks of life. Treatment of RDS focuses on surfactant
administration to decrease alveolar surface tension and improve pulmonary compliance
(Jobe, 2008). The use of fluid restriction is meant to prevent pulmonary edema thereby
reducing the need for high amounts of positive pressure and prolonged mechanical
ventilation that lead to the development of BPD (Oh et al., 2005).
Cardiovascular Complications
The development of BPD may also be influenced by the presence of a PDA
within the first few weeks of life (Stephens et al., 2008). A PDA occurs when the fetal
shunt called the ductus arteriosus (DA) fails to close after birth. In utero, blood enters the
pulmonary artery from the left ventricle but is shunted through the DA due to high
resistance in the pulmonary vasculature (Lee & Jain, 2000). After birth, the pulmonary
vasculature decreases significantly in response to a high oxygen environment leading to
closure of the DA (Gleason & Devaskar, 2012). The ELBW infant is born with RDS and
lacks sufficient intra-arterial oxygen concentrations and arterial musculature to close the
DA resulting in a PDA (Baumgart, 2008).
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A PDA allows oxygenated blood from the aorta to shunt across the DA into the
lungs resulting in pulmonary edema. The shunting of blood across the DA results in
hypotension and decreased systemic perfusion. A PDA left untreated may result in
congestive heart failure and decreased kidney perfusion resulting in low urine output
(Baumgart, 2008).
The treatment of a PDA is aimed at closing the DA. Medications can be given that
work to decrease prostaglandin synthesis thought to be a contributor in the persistence of
a PDA after birth. However, initial fluid restriction during the first few days of life is
recommended to prevent fluid volume overload that may occur before postnatal diuresis
takes place (Stephens et al., 2008).
Gastrointestinal Complications
Fluid volume overload during the first week of life has been associated with an
increased risk for necrotizing enterocolitis (NEC) (Bell & Accargeui, 2010). NEC is a
disease more commonly seen in premature infants and its incidence increases as
gestational age decreases (Neu, 2008). The exact pathogenesis of NEC is currently
unknown. But certain factors are known to be associated with its development, which
includes: an immature gastrointestinal system with a decreased barrier function, presence
of an infectious organism, commencement of enteral feedings that provide a substrate for
infection, and a possible ischemic or thromboembolic event (Lee & Jain, 2000; Neu,
2008).
The clinical manifestations of NEC are characterized by abdominal distension and
tenderness, feeding intolerance with large feeding residuals, bloody stools, bowel
perforation, and intestinal necrosis. The diagnosis of NEC is done with abdominal x-ray
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where pneumatosis intestinalis, or gas in the bowel wall, is seen (Neu, 2008). Treatment
of NEC involves antibiotic therapy, gastric decompression, and in the most severe cases
surgical resection of the necrotic bowel with ilieostomy.
The severity of NEC and its associated morbidity and mortality have resulted in
care providers withholding enteral feedings during the first few weeks of life in the
ELBW infant (Adamkin, 2005). Withholding feedings to prevent NEC for long periods of
time has been known to cause intestinal atrophy and further delay the development of the
ELBW infant’s gastrointestinal system (Neu, 2008). Prolonged periods of NPO status
require the ELBW infant to receive total parenteral nutrition (TPN) for weeks and even
months at a time placing them at risk for poor growth and nutritional deficiencies.
Metabolic Complications
One of the most common nutritional deficiencies seen in the ELBW infant is
osteopenia of prematurity. Osteopenia of prematurity is a metabolic bone disease due to
poor bone mineralization in the premature infant (Greer, 2008). The disease is
characterized by calcium, phosphorus and vitamin D deficiencies. The disruption in
mineral supply that occurs upon birth results in a bone remodeling process that increases
bone resorption thereby decreasing bone density in the ELBW infant (Rigo, Pieltain,
Salle & Senterre, 2007). Failure to provide adequate calcium, phosphorus and vitamin D
exacerbates bone resorption leading to bone mineral content changes and possible
fractures.
Neurodevelopment
Failure to provide adequate nutritional support in the ELBW infant not only
results in poor bone mineralization but it decreases extrauterine growth resulting in poor
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neurodevelopmental outcomes. Ehrenkranz et al. (2006) found that when extrauterine
growth was increased from 12 to 21 grams/kg/day the incidence of cerebral palsy,
abnormal neurologic examination and impaired neurodevelopment fell significantly.
Stephens et al. (2009) found that the early administration of energy and protein in ELBW
infants improved their neurodevelopmental outcomes. An increase of 10kcal/kg/day
improved performance on the mental development index (MDI) by 4.6 points and for
every gram/kg increase in protein intake MDI scores improved by 8.6 points (Stephens,
et al., 2009).
Neurodevelopment is perhaps the most important outcome for the ELBW infant
since they are born with an immature brain and nervous system. Intraventricular
hemorrhage (IVH) is common in the ELBW infant due to their inability to regulate
cerebral blood flow resulting in the rupture of blood vessels located in the germinal
matrix, which is a highly vascularized area of the brain that regresses in size as gestation
progresses and fully involutes at 34-36 weeks (Lee & Jain, 2000). In addition,
malnutrition during a time of early brain development leads to the overall decrease in
brain cells leading to memory loss, behavior issues and learning deficits (Ehrenkranz et
al., 2006).
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PART III: EVIDENCE TABLES
Fluid & Electrolyte Management
PICO Question: What type of fluid and electrolyte regimen meets the fluid and
electrolyte needs of the ELBW infant?
Search terms: fluid intake, water intake, electrolyte requirement, sodium intake,
potassium intake, fluid and electrolyte management, premature infant, low birth weight
infant, very low birth weight infant, and extremely low birth weight infant
Summary of findings:
A systematic review of premature infants and two observational studies in ELBW
infants supported fluid restriction to prevent PDA, NEC, and BPD. Two RCTs were done
in ELBW infants and found sodium restriction during the first few days of life promotes
postnatal diuresis. An observational study in ELBW infants found that potassium should
also be held in the first few days of life due to the risk of non-oliguric hyperkalemia.
However, no studies were found that addressed daily maintenance requirements for
sodium or potassium supplementation so, recommendations from the 2004 American
Academy of Pediatrics (AAP) Committee on Nutrition were used.
Insensible Water Loss
PICO Question: Does humidification improve fluid and electrolyte management of the
ELBW infant?
Search Terms: insensible water loss, fluid and electrolyte management, premature infant,
low birth weight infant, very low birth weight infant, and extremely low birth weight
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Summary of findings:
Clinical trials to determine the use of humidity to improve fluid and electrolyte
balance in the ELBW are lacking. Two retrospective chart reviews were done after
humidified isolettes were implemented in two different NICUs with similar findings of
improved fluid and electrolyte management along with a decrease in insensible water
loss.
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Table 1: Fluid & Electrolyte Management
Author/Year

Bell & Acarregui
2010

Study Design
Level of Evidence
Systematic
Review

I

Study Purpose/Study Sample
Study Intervention/Study Outcome
Fluid Management
Purpose: To investigate the effect of
water intake on postnatal weight loss.
The risks of dehydration, PDA, NEC,
BPD, IVH and death in premature
infants.
Sample: 5 RCTs including preterm
infants born at less than 37 weeks
gestation.
Intervention: Varying intakes of water
given intravenously.
Primary Outcomes: postnatal weight
loss, dehydration

Oh et al., 2005

Retrospective
Review of RCT

IV

Secondary Outcomes: PDA, NEC,
BPD, oxygen requirement at 28 days of
life and 36 weeks PCA, IVH, and death
before discharge.
Purpose: To determine the association
between fluid intake and postnatal
weight loss on the development of BPD
among ELBW infants.
Sample: 1,382 ELBW infants born
from October 1999-August 2001
included in the Neonatal Research
Network Study on Glutamine
Supplementation.

Results

Fluid restriction resulted in a
higher postnatal weight loss.
The risk of PDA, NEC, and
death was significantly lower
with fluid restriction.

GRADE Quality
of Evidence
High
Study
Limitations
None

Water intake had no significant
effect on BPD or IVH in
premature infants.
Fluid restriction had a nonsignificant trend toward
dehydration.

Higher fluid intake given during
the 2nd to 10th day of life was
associated with the development
of BPD. Infants given a higher
amount of fluid had less weight
loss and a significantly higher
risk of BPD and death.

Low
Study
Limitations
Retrospective
Review

Intervention: Varying fluid and
sodium intake determined by the
attending neonatologist.

Stephens et al.,
2008

Retrospective
Cohort

IV

Outcomes: weight loss, BPD, and
death
Purpose: To determine the effect of
fluid intake on PDA, BPD and caloric
intake in the ELBW infant.
Sample: 204 infants born at less than
32 weeks gestation and less than 1,250
grams.
Intervention: Infants were
divided into 3 groups based on the
amount of fluid intake prescribed by
the attending neonatologist
Outcomes: PDA, BPD, and caloric
intake

Gaylord, Wright,
Lorch, Lorch &
Walker, 2001

Retrospective
Chart Review

IV

Insensible Water Loss
Purpose: To compare fluid and
electrolyte management in ELBW
infants nursed in humidified versus
non-humidified isolettes.
Sample: 155 ELBW infants admitted
the NICU over a 4 year period.
Intervention: care provided in a
humidified versus a non-humidified
isolette.
Primary Outcomes: total daily fluid
requirement, weight, urine output,
serum electrolytes, incidence of PDA
and BPD.
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Infants who required the highest
fluid intake were of lower
gestational age and birth weight
and had increased rates of PDA.
The amount of fluids given
during the first 3 days of life
and during the first week of life
was significantly associated
with higher rates of BPD and
PDA. Fluid intake
(>170ml/kg/d) administered in
the first few days of life is
significantly associated with
higher PDA rates. No difference
in caloric intake was found.
Infants who were not cared for
in humidified isolettes had
higher fluid intake, less hourly
urine output and more likely to
have hypernatremia,
hyperkalemia, and azotemia.
No difference in the incidence
of BPD or PDA between the
groups.
A higher number of gram
negative isolates were found in
the group who received
humdification.

Low
Study
Limitations
Retrospective
Chart Review

Low
Study
Limitations
Retrospective
Chart Review

Kim, Lee, Chen &
Ringer, 2010

Retrospective
Chart Review

IV

Purpose: To identify changes in
temperature, fluid and electrolyte
management, growth and short term
outcomes in ELBW infants nurse in
humidified hybrid incubators compared
to a cohort of patients cared for in a
non-humidified incubator.
Sample: 182 ELBW infants admitted
to the NICU over a 3 year period.
Intervention: care provided in a hybrid
humidified isolette versus nonhumidified isolette.
Primary Outcomes: temperature
control, fluid intake, electrolyte
balance, growth velocity.
Secondary Outcomes: mortality, PDA,
BPD, NEC, IVH and sepsis.

Infants who received care in the
hybrid humidified isolette had
less fluid intake, urine output,
insensible water loss, weight
loss, and hypernatremia during
the first week of life.

Low
Study
Limitations
Retrospective
Chart Review

Infants in the hybrid humidified
isolette had less lab draws for
electrolytes and less blood
transfusions.
Infants in the hybrid humidified
isolettes had a higher incidence
of hyponatremia on postnatal
day 1 and higher growth
velocity.
Benefits were of the humidified
hybrid isolette were more
pronounced in infants with
weight less than 750 grams.
No difference in sepsis, NEC,
IVH, or BPD, but infants who
received care in a nonhumidified isolette had an
increased incidence of severe
BPD and need for mechanical
ventilation.

Costarino,
Gruskay,
Corcoran, Polin &
Baumgart, 1992

RCT

II

Sodium Supplementation
Purpose: To compare a salt restricted
parenteral fluid regimen to a salt
supplemented regimen.
Sample: 17 infants born at less than or
equal to 28 week gestation with a birth
weight less than 1,000 grams
Intervention: Sodium supplementation
with 3-4meq/kg/day given for 5 days
(treatment) versus no sodium given for
5 days (control).
Outcomes: sodium intake, fluid intake,
urine output, FENa, and GFR.

Shaffer & Meade,
1989

RCT

II

Purpose: To assess extracellular fluid
volume regulation in very low birth
weight infants.
Sample: 20 infants with a birth weight
between 700 and 1,500 grams.
Intervention: 3meq/kg/day of sodium
versus 1meq/kg/day given
intravenously or by mouth.
Outcomes: sodium intake, sodium
balance, body water composition

Sodium supplementation
resulted in sodium balance of
zero during the first 5 days of
life.
Sodium restricted infants had
high rates of sodium excretion
promoting a negative sodium
balance.
Increased fluid intake was noted
in infants supplemented with
sodium.
Infants who were sodium
restricted were more likely to
have a normal serum osmolality
and a decreased incidence of
BPD.
Both groups had neither dilute
nor concentrated urine and had a
high rate of FENa.
Serum sodium levels increased
significantly in both groups.
Body weight decreased in both
groups during the first 5 days of
life.
ECFV* decreased in both
groups during the first 10 days
of life and stabilized. Sodium
balance was negative in both
groups but became positive by
10 days of age. Sodium
excretion was higher in the
3meg/kg/day group during the
first 10 days of life; after days
20 and 30 with no difference.
Urine sodium and FENa
increased in the 3meq/kg/day
group between days 1 and 5 of
life whereas urine sodium and
FENa decreased in the
1meq/kg/day group.
Hyponatremia occurred more
often in the 1meq/kg/day group.
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High
Study
Limitations
None

Moderate
Study
Limitations
No discussion of
blinding or
allocation
concealment

Lorenz, Kleinman
& Markarian, 1997

Observational
Cohort

IV

Potassium Supplementation
Purpose: To characterize potassium
metabolism during the three phases of
fluid and electrolyte homeostasis.
Sample: 31 infants with birth weight
less than 1,000 grams
Intervention: Use of potassium plasma
concentration, potassium intake and
output, and renal clearances to
determine potassium metabolism
Primary Outcomes: serum potassium
values.

Potassium values increased
initially after birth despite
potassium supplementation.
Serum potassium levels peaked
upon postnatal diuresis and
decreased significantly once
postnatal diuresis was complete.
Infants who developed
hyperkalemia were noted to
have higher serum potassium
levels within 12 hours of birth.

Potassium excretion decreased
after postnatal diuresis despite
an increase in potassium
supplementation.

Note. ECFV=extracellular fluid volume
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Low
Study
Limitations
None

Mineral Requirements
PICO Question: What intake of calcium, phosphorus, and magnesium is required to meet
the needs of the ELBW infant and promote bone mineralization?
Search Terms: calcium intake, phosphorus intake, magnesium intake, mineral intake,
bone mineralization, osteopenia of prematurity, premature infant, low birth weight infant,
very low birth weight infant and extremely low birth weight infant.
Summary of findings:
The recommended intake of calcium, phosphorus and magnesium has been
estimated based on intrauterine accretion rates (AAP Committee on Nutrition, 2004). One
RCT in infants less than 1,200 grams investigated using higher intakes of calcium and
phosphorus in parenteral nutrition to improve mineral retention and bone mineral content
and found administering higher rates of calcium and phosphorus in TPN improved early
and long term bone mineralization.
Table 2: Mineral Requirements
Author/Year

Prestidge, Schanler,
Shulman, Burns &
Laine, 1993

Study Design
Level of Evidence
RCT

I

Study Purpose/Study Sample
Study Intervention/Study Outcome

Results

Purpose: To determine the
accumulative effects of increasing the
quantities of calcium and phosphorus
in TPN.

Improved calcium and phosphorus
retention was significantly higher in
the HIGH group.

Sample: 24 infants with birth weight
less than 1,200 grams expected to
have parenteral nutrition for at least 3
weeks.
Intervention: Standard concentration
of calcium (1.25mmol) and
phosphorus (1.5mmol) in parenteral
nutrition versus High concentration of
calcium (1.7mmol) and phosphorus
(2mmol) in parenteral nutrition.
Outcomes: retention of calcium and
phosphorus and BMC*.

Note. BMC=bone mineral content
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Serum calcium, magnesium,
parathyroid hormone, 25hydroxyvitamin D, and osteocalcin
were similar in both groups.
Serum phosphorus levels were
significantly higher in the HIGH
group.
BMC* and the rates of increase in
BMC* were improved between
weeks 1 and 4, 1 and 8, and 1 and
26 weeks PCA* in the HIGH.
TPN used in this study contained
cysteine

GRADE
Quality of
Evidence
High
Study
Limitations
None

Energy Requirements
PICO Question: How many calories are needed to meet the energy expenditure of the
ELBW infant?
Search Terms: energy intake, caloric intake, energy expenditure, energy balance,
premature infant, low birth weight infant, very low birth weight infant, and extremely low
birth weight infant
Summary of Findings:
Evidence is lacking to determine the energy requirements for the ELBW infant
with most of the studies being conducted in healthy growing premature infants. One
observational study compared energy expenditure in a group of ELBW infants to a group
of critically ill term infants and found that energy expenditure in the ELBW was much
higher than current estimates. A RCT investigated energy intake along with varying
amounts of protein intake and found that a higher caloric intake of greater than
70kcal/kg/day given with 2.7-3.5g/kg/day of protein leads to improved nitrogen retention
and increased weight gain. Expert opinion recommends providing enough caloric intake
to mimic intrauterine growth rates with energy requirements estimated utilizing the
studies included in the evidence table (Hay, 2005; Leitch & Denne, 2005).
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Table 3: Energy Requirements
Author/Year

Carr, Denne &
Leitch, 2000

Study Design
Level of Evidence
Observational
Cohort

Study Purpose/Study Sample
Study Intervention/Study Outcome
IV

Purpose: To compare total daily
energy expenditures and energy
intakes in extremely premature
infants to critically ill and healthy
term infants.

Results

Total energy expenditure was
higher in the extremely premature
infant and estimated to
84.1+33.3kcal/kg/day.

Sample: 10 ELBW infants less than
28 weeks gestation.

GRADE
Quality of
Evidence
Low
Study
Limitations
Study findings
were in abstract
form only.

Intervention: Measurement of total
energy expenditure and total body
water using a double labeled water
method in ELBW and term infants
given varying caloric intake.

Zlotkin, Bryan &
Anderson, 1981

RCT

II

Primary Outcomes: total energy
expenditure, total body water, energy
intake.
Purpose: To evaluate the individual
and combined effects of energy and
nitrogen intake on nitrogen retention
and growth.
Sample: 22 appropriate for
gestational age premature infants
greater than 4 days of age.
Intervention:
Group 1: 50kcal/kg/d + 80mg/kg/d
N*
Group 2: 50kcal/kg/d + 640mg/kg/d
N*
Group 3: 80kcal/kg/d + 320mg/kg/d
N* Group 4: 80kcal/kg/d +
480mg/kg/d N*Group 5: 80kcal/kg/d
+ 640mg/kg/d N*
Group 1 & 2 received glucose as sole
energy source. Group 3-5 were
randomly assigned and received
energy as glucose plus IL*.
Outcomes: N* balance and weight
gain.

Note. IL=intralipid, N=nitrogen
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Increased non-protein energy
resulted in improved nitrogen
retention and weight gain.
Increasing nitrogen intake while
leaving energy intake constant had
no effect on nitrogen retention.
Increasing energy intake along
with nitrogen intake correlated
significantly with improved
nitrogen retention. Providing
energy intake of greater than
70kcal/kg/day and 2.7-3.5g of
protein/kg/d resulted in
duplication of intrauterine nitrogen
accretion rates.

Moderate
Study
Limitations
Lack of
blinding. No
discussion of
allocation
concealment

Glucose Management
PICO Question: What glucose infusion rate meets the needs of the ELBW infant? Should
hyperglycemia in the ELBW infant be treated with glucose restriction or insulin infusion?
Search Terms: glucose infusion rate, glucose infusion, intravenous glucose,
hyperglycemia, premature infant, low birth weight infant, very low birth weight infant,
and extremely low birth weight infant
Summary of findings:
Clinical trials are lacking to determine the appropriate glucose infusion rate for
the ELBW infant so, experts suggest utilizing intrauterine glucose infusion rates as a
guide for administering glucose to the ELBW infant (AAP Committee on Nutrition,
2004; Hay, 2005). Two systematic reviews were found, one that addresses the prevention
of hyperglycemia and one that addresses the treatment of hyperglycemia. Findings in
these systematic reviews confirm the lack of evidence in determining the appropriate
glucose infusion rate for administering glucose and in treating hyperglycemia in the
ELBW infant. The use of insulin to prevent hyperglycemia is not recommended due the
high rate of death before 28 days of age associated with using insulin as a prophylaxis
against hyperglycemia.
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Table 4: Glucose Management
Author/Year

Sinclair, Bottino &
Cowett, 2011

Study Design
Level of Evidence
Systematic
Review

Study Purpose/Study Sample
Study Intervention/Study Outcome
I

Purpose: To assess the effects of
interventions for prevention of
neonatal hyperglycemia in infants
with birth weights less than 1,500
grams receiving or intending to
receive total or partial parenteral
nutrition
Sample: 4 RCTs involving infants
less than 32 weeks gestation and birth
weight less than 1,500 grams
receiving or intended to receive
parenteral nutrition without
hyperglycemia at the start of the
study.

Results

Insufficient evidence exists to
inform clinical practice on the rate
of glucose infusion.
Insulin decreases blood sugar
levels but its use to prevent
hyperglycemia is not
recommended for practice as it is
associated with death before 28
days of age.

GRADE
Quality of
Evidence
High
Study
Limitations
None

Intervention: Restriction versus no
restriction of glucose infusion.
Insulin therapy versus restriction in
the rate of glucose infusion.
Insulin therapy versus no restriction in
the rate of glucose.
Primary Outcomes: mortality,
neurodevelopmental impairment,
growth at 36 weeks PCA, blood
glucose concentrations

Bottino, Cowett &
Sinclair, 2011

Systematic
Review

I

Secondary outcomes: caloric intake,
cumulative parenteral glucose intake,
hypoglycemia, nitrogen accretion,
sepsis, NEC, CLD*, length of hospital
stay, and levels of insulin growth
factor.
Purpose: To examine the effects of
interventions for treating neonatal
hyperglycemia in the very low birth
weight infant who is receiving total or
partial parenteral nutrition.
Sample: 2 RCTs involving infants
with birth weight less than 1,500
grams and born at less than 32 weeks
gestation.
Intervention: Reduction of glucose
infusion rate versus no reduction in
glucose infusion rate.

Insufficient evidence exists to
determine if treatment
interventions for hyperglycemia
are associated with an increased
risk of morbidity or mortality.
Insulin infusion was associated
with a higher intake of energy and
glucose resulting in improvement
in short term growth, but the
importance of these outcomes
could not be determined.

Insulin infusion versus no reduction in
glucose infusion rate.
Insulin infusion versus reduction in
glucose infusion rate.
Primary outcome: all cause
mortality, neurodevelopmental
impairment, severe IVH, ROP*,
bacterial and fungal sepsis
Secondary outcomes: time to resolve
hyperglycemia, recurrent episodes of
hyperglycemia, hypoglycemia, caloric
intake, NEC, duration of mechanical
ventilation, CLD*, and length of
hospital stay.

Note. CLD=chronic lung disease, ROP=retinopathy of prematurity
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High
Study
Limitations
None

Early Aggressive Nutrition
PICO Question: Does an early aggressive nutrition plan that includes early administration
of amino acids, intralipids, and minimal enteral feedings improve growth of the ELBW
infant?
Search Terms: total parenteral nutrition, amino acid intake, protein intake, intravenous
amino acids, intravenous fat emulsion, intralipid, intravenous fat, lipid infusion,
parenteral lipid, lipid emulsion, trophic feedings, minimal enteral feedings, growth,
premature infant, low birth weight infant, very low birth weight infant, and extremely low
birth weight infant.
Summary of findings:
Clinical studies to determine the best nutritional method for promoting growth in
the ELBW infant are minimal. Most studies include very low birth weight (VLBW)
infants who weigh less than 1,500 in order to obtain an adequate sample size. Two RCTs
have shown that an early aggressive nutritional regimen leads to an improved caloric
intake within the first few days of life as well as a positive nitrogen balance. In one of the
RCTs early aggressive nutrition was associated with improved growth within the first
week of life and prior to discharge.
Part of early nutrition requires the administration of amino acids and intralipids
shortly after birth. Eleven RCTs have been conducted to examine the effect of early
administration versus the late administration of amino acids in premature infants with
birth weights ranging from 500 grams to 2,000 grams. The early administration of protein
has been shown to prevent catabolism, promote nitrogen balance and protein synthesis
without increasing blood urea nitrogen (BUN) levels and disrupting acid base balance. A
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systematic review of early intralipid administration found that no adverse effects were
associated with intralipid administration but its use could not be recommended for
promoting short term growth.
Minimal enteral feedings (MEF) or trophic feedings are the last component of an
early aggressive nutrition plan. In a systematic review trophic feedings were found to
have no statistical effect on growth or development, but no harm or adverse effects
including NEC were found to be associated with administering trophic feedings. These
findings were further supported in another systematic review that found delaying enteral
nutrition did not reduce the risk of NEC.
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Table 5: Early Aggressive Nutrition
Author/Year

Ibrahim, et al., 2004

Study Design
Level of Evidence
RCT

II

Study Purpose/Study Sample
Study Intervention/Study Outcome
Early Aggressive Nutrition
Purpose: To determine if early
aggressive TPN vs. late TPN will
improve nitrogen and energy balance.
To determine if any complications
with early aggressive TPN will occur.

Results

GRADE Quality
of Evidence

Early TPN= higher nitrogen
retention, higher caloric intake
within 5 days of life and greater
mean serum bilirubin levels with
no clinical difference.

Moderate
Study
Limitations
No blinding of
intervention

Sample: 32 infants with birth weights
between 501 to 1250 grams and
gestational ages of 24 to 32 weeks.

Late TPN group= higher mean
serum glucose concentrations.
No difference in complications.

Intervention: Early TPN: 3.5g/kg/d
of AA* +3g/kg of IL* within 2 hours
of birth versus Late TPN: Dextrose
and 2g/kg AA* at 48h of life +
0.5g/kg of IL* 48h after, which both
increased by 0.5g/kg/d to a max of
3.5g/kg AA* and 3g/kg IL*
Primary outcomes: Nitrogen balance
and caloric intake.

Wilson et al., 1997

RCT

II

Secondary outcomes: BPD, IVH,
PDA, ROP*, and sepsis.
Purpose: To improve energy intake in
sick VLBW infants; to decrease
growth problems, lessen pulmonary
morbidity, shorten hospital stay, and
avoid possible feeding related
morbidities with an early aggressive
nutrition regimen.
Sample: 125 infants with birth weight
less than 1,200 grams or infants with
birth weights of 1,200 to 1,499 grams
requiring mechanical ventilation
within 24 hours of birth

Infants who received early
aggressive nutrition had higher
energy intake with less weight
loss after birth and took less time
to regain their birth weight.
Infants in the treatment group had
improved weight gain, length and
head circumference at discharge.
No difference was found in length
of stay or pulmonary morbidities.

Intervention: Control group: Glucose
alone until DOL 3
AA* 1g/kg/d on DOL 3 advanced by
0.5/g/kg/d to max of 2g/kg/d; IL*
0.5g/kg/d on DOL* 5 advanced by
0.5g/kg/d to max of 2g/kg/d
Enteral feeds introduced when
clinically stable.

High
Study
Limitations
Interventions
were unable to be
blinded but
clinical outcomes
were pre-defined
to help control
for blinding.
Observers of
biochemical and
radiological data
were blinded to
group
assignment.

Treatment Group: Glucose +AA* at
0.5g/kg advanced by 0.5g/kg/d to a
max of 3.5g/kg/d; IL* 0.5g/kg/d
started DOL* 2 advanced by
0.5g/kg/d to max of 3.5g/kg/d. Enteral
feeds 0.5ml/h at 12h of life.
Outcomes: time to regain birth
weight, days of oxygen therapy, days
of mechanical ventilation and days to
discharge.
Early Administration of Protein
Anderson, Beiber &
Heird, 1979

RCT

II

Purpose: To determine the efficacy of
two isocaloric nutrition regimens
administered intravenously.
Sample: 14 preterm infants
appropriate for gestational age whose
clinical condition precluded oral
feedings for at least 5 days.
Intervention: IV glucose vs. glucose
+ 2g/kg/day of AA* given for 5 days.
Outcomes: electrolytes, BUN, acid
base status, plasma AA* levels,
nitrogen balance.
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Infants who received AA* had
positive nitrogen balance.
Infants who received glucose
alone had significantly lower total
essential AA* and total AA*
concentrations.
Infants who received AA*
developed essential fatty acid
deficiency.

Moderate
Study
Limitations
No blinding and
no discussion of
allocation
concealment

Blanco et al., 2011

RCT

II

Purpose: To examine changes in
plasma AA* levels over time when
ELBW infants are provided standard
AA* supplementation or an early and
high AA* supplementation.
Sample: 62 ELBW infant less than 12
hours of age.
Intervention: AA* at 0.5g/kg/day
started within 24 to 36 hours of life
and advanced by 0.5g/kg/day to a
maximum of 3g/kg/d and continued
for 7 days vs. AA* at 2g/kg/day
started within 24 hours of life and
advanced by 1g/kg/day to a maximum
of 4g/kg/day and continued for 7 days.

Clark, Chase &
Spitzer, 2007

RCT

II

Outcomes: AA* Levels
Purpose: To measure the effects of 2
distinct strategies for parenteral
nutrition on neonatal growth and
blood AA* profiles.

Total AA* concentrations,
including essential and
nonessential AA* concentrations
were higher in the early and high
AA* group. Essential and total
AA* concentrations were higher
at day 1 and 3 in the early and
high AA* group. Non-essential
AA* concentrations were only
different on day 3 in the early and
high AA* group.

No difference between the two
groups for growth or morbidities;
Infants in the high AA* group
had higher AA* levels than the
low AA* group.

High
Study
Limitations
None

High
Study
Limitations
None

Sample: 122 infants born at 23-29 6/7
weeks gestational age
Intervention: 2.5g/kg/day of AA*
(started at 1g/kg/d and advanced by
0.5g/kg/d-low group) vs. 3.5g/kg/day
of AA* (started at 1.5g/kg/d and
advanced by 1g/kg/d-high group). IL*
started at same time as TPN at
0.5g/kg/d and advanced by 0.5/kg/d.
GIR* rate 8-12mg/kg/min; no use of
Insulin. AA* limited to 1g/kg/d for
low AA* group; 2g/kg/d for high
AA* group when feeds at 80100ml/kg/d. Completed treatment
once on full feedings.

Murdock, Crighton,
Nelson & Forsyth,
1995

RCT

II

Outcome: growth and plasma AA*
levels.
Purpose: To compare the
biochemical tolerance of 3 different
parenteral nutrition regimens
administered within the first 48 hours
of life.
Sample: 29 infants with birth weight
less than 2,000 grams who could not
receive enteral feedings directly after
birth.

Plasma AA* fell immediately in
the glucose only group.
Hypoglycemia occurred more
frequently in the glucose + AA*
group and the least commonly in
the glucose +AA*+ IL*. No
difference in the groups for
triglyceride and cholesterol levels
within 48 hours of administering
IL*.

Moderate
Study
Limitations
No blinding or
discussion of
allocation
concealment

Significant difference in weight,
length and head circumference at
36 weeks post conceptual age in
favor of early AA* group.

High
Study
Limitations
None

Intervention: 10% glucose infusion
vs. 10% glucose infusion + AA* vs.
10% glucose infusion + AA* + IL*

Poindexter, Langer,
Dusick &
Ehrenkranz, 2006

RCT

II

Outcomes: AA* profile, cholesterol,
triglycerides, acid base status, glucose
levels.
Purpose: To determine whether early
administration of parenteral AA* is
associated with better growth and
neurodevelopmental outcomes
Sample: 1,018 infants with birth
weight of 401 to 1,000 grams and
enrolled within 72 hours of life.
Intervention: Administration of
3g/kg/day or greater of AA* within
first 5 days of life (early) vs. less than
3g/kg/day of AA* given in the first 5
DOL* (late).
Outcomes: growth (weight, length
and head circumference) and
neurodevelopmental outcomes.
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The odds of having a weight less
than the 10th percentile was 4 fold
higher in the late AA* group with
male infants twice as likely to
have a head circumference below
the 10th percentile.
No difference was found in
neurological or developmental
outcomes or growth parameters
between the 2 groups at 18
months corrected age.

Rivera, Bell & Bier,
1993

RCT

II

Purpose: To provide information on
the safety and efficacy of AA*
administration to low birth weight
infants during the first 3 days of life.

Infants who received AA* had
positive nitrogen balance, whole
body protein balance as a result of
increased protein synthesis.

Sample: 23 preterm infants with RDS
requiring mechanical ventilation and
indwelling arterial catheters during
the first 3 days of life.

Early administration of AA* was
deemed safe with no differences
in electrolytes or ammonia, BUN
levels.

Moderate
Study
Limitations
No blinding

Intervention: Glucose alone vs.
glucose +1.5g AA*/kg/day
administered on the first day of life.

TeBraake, Van Den
Akker, Wattimena,
Huijmans & Van
Goudoever, 2005

RCT

II

Outcomes: nitrogen balance, AA*
levels, protein kinetics, electrolytes,
ammonia, and BUN levels.
Purpose: To test the administration of
2.4grams AA*/kg/d in VLBW infants
to see if it is safe and results in
positive nitrogen balance.
Sample: 135 premature infants with
birth weight equal to or less than 1500
grams.
Intervention: Administration of
2.4g/kg/d of AA* within 2H of birth
and 5.5mg/kg/min of Glucose
(treatment group) versus glucose at
5.5mg/kg/day after birth, with
administration of 1.2g/kg/d AA* on
the first day of life and advancement
to 2.4g/kg/d on the third day of life
(control group).

Thureen, Melara,
Fennessey & Hay,
2003

RCT

II

Outcomes: Nitrogen balance, AA*
concentrations, metabolic acidosis,
and glucose levels.
Purpose: To assess the safety and
efficacy of early AA* intake
mimicking intrauterine accretion rates

Sample: 28 infants with birth weight
less than or equal to 1,300 grams and
requiring mechanical ventilation.

Treatment group had more infants
who received prenatal steroids.
Treatment group had higher BUN
levels on Day 2 with no
difference in levels on Day 4.
Treatment group had improved
nitrogen intake, positive nitrogen
balance on day 2, and higher AA*
levels.

Moderate
Study
Limitations
Caregivers were
not blinded to the
intervention and
infants in the
treatment group
received more
prenatal steroids.

No adverse effects were found
between the two groups.

Infants receiving 3g/kg/d of AA*
had increased protein accretion
through increase protein synthesis
rather than through the prevention
of protein breakdown.
No significant difference in
metabolic acidosis, use of sodium
bicarbonate or BUN levels.

Moderate
Study
Limitations
Lack of blinding
and no
discussion of
allocation
concealment

Intervention: 1g/kg/d of AA* versus
3g/kg/d of AA* given intravenously.

Van Goudoever, et
al., 1995

RCT

II

Outcomes: protein balance, acid base
status, and BUN levels.
Purpose: To gain information on
protein kinetics after AA*
supplementation.
Sample: 18 preterm infants less than
2,000 grams needing mechanical
ventilation and umbilical catheters.
Intervention: Glucose only (control)
vs. Glucose + AA* delivered after
birth.
Outcomes: nitrogen balance, protein
synthesis, AA* profile, blood pH,
BUN and glucose levels.

No difference in blood pH, base
excess, urea concentration or
glucose levels.
Total AA* concentration and
essential AA* concentration were
significantly lower and below
references ranges in the control
group.
Nitrogen retention was improved
in the treatment group.
Improved protein balance due to
enhanced protein synthesis rather
than increased protein
breakdown.
Cysteine levels were highly
predictive for protein synthesis in
the treatment group.
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Moderate
Study
Limitations
Lack of blinding
and no
discussion of
allocation
concealment

Van Lingen, Van
Goudoever,
Luijendijk,
Wattimena &
Sauer, 1992

RCT

II

Purpose: To evaluate the effect of
AA* administration given during the
second day of life on protein turnover
and nitrogen balance.
Sample: 18 preterm infants
appropriate for gestational age
Intervention: Glucose alone was
administered to both groups on the
first postnatal day. Group A: glucose
+ AA*+IL* versus Group B: glucose
+ IL* until postnatal day 4 when AA*
were added to the regimen.

Group A had higher protein flux
and higher protein synthesis.
No difference in protein
breakdown between the 2 groups.
Administration of AA* resulted
in positive nitrogen balance.

Moderate
Study
Limitations
Lack of blinding
and no
discussion of
allocation
concealment

No adverse effects of AA*
administration were found.

Outcomes: protein turnover and
nitrogen balance.
Early Administration of Intralipids
Simmer & Roa,
2009

Systematic
Review

I

Purpose: To assess the effect of early
administration of IL* on growth, the
risk of CLD* and other respiratory
morbidities, NEC, IVH, ROP*, PDA,
sepsis, thrombocytopenia, jaundice,
and death in premature infants being
fed parenterally.

The early administration of IL*
has no statistically significant
effect on short term nutrition or
other clinical outcomes.

Sample: 7 RCTs assessing the effect
of early versus late administration of
IL*

The use of early administration of
IL* cannot be recommended for
short term growth or to prevent
mortality or morbidity in
premature infants.

Intervention: Early introduction of
IL* (less than 5 DOL*) versus late
introduction of IL* (greater than 5
DOL*)

High
Study
Limitations
None

Neither benefits nor adverse
outcomes were found in
administering IL* early.

Primary Outcomes: weight, length,
head circumference, incidence CLD*,
death
Secondary Outcomes: respiratory
morbidities, NEC, PDA, ROP*, IVH,
sepsis, thrombocytopenia, and
jaundice.
Minimal Enteral Feedings (MEF)
Bombell &
McGuire, 2009

Systematic
Review

I

Purpose: To determine the effect of
trophic feedings on feeding tolerance,
growth and development, the
incidence of NEC, infection, and
mortality.

Trophic feedings do not have a
statistically significant effect on
feeding tolerance, growth and
development, NEC, infection or
mortality.

Sample: 8 RCTs investigating trophic
feedings in infants less than 32 weeks
gestation and weighing less than
1,500 grams at birth.

Trophic feedings were not
associated with clinical harm.

Intervention: Early trophic feeding
(milk volumes up to 24ml/kg/day)
within 4 days of birth continued for at
least 7 days vs. enteral fasting for 1
week.
Primary Outcomes: feeding
tolerance, NEC.
Secondary Outcomes: mortality prior
to discharge, growth,
neurodevelopment, infection,
hyperbilirubinemia, and duration of
hospital say.
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High
Study
Limitations
None

Morgan, Young &
McGuire 2011

Systematic
Review

I

Purpose: To determine the effect of
delaying the advancement of enteral
feedings on the incidence of NEC,
mortality and other morbidities in
very low birth weight infants

Delaying the advancement of
enteral feedings does not reduce
the risk of NEC, mortality or
other morbidities.

High
Study
Limitations
None

Sample: 5 RCTs with 600 premature
infants less than 32 weeks gestation
with birth weights less than 1,500
grams
Intervention: Delayed advancement
of enteral feeds (more than 4 days
after birth) vs. early advancement of
enteral feedings
Primary Outcomes: NEC and all
cause mortality during the neonatal
period and prior to hospital discharge.
Secondary Outcomes: growth (short
term and long term),
neurodevelopment, time to establish
full enteral feeding, time to establish
oral feedings, feeding intolerance,
incidence of invasive infection and
length of stay.

Note. AA= amino acids, CLD=chronic lung disease, DOL= day of life GIR=glucose infusion
rate, IL=intralipids, ROP=retinopathy of prematurity
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Enteral Nutrition
Human Milk
PICO Question: What type of feeding (human milk or formula) promotes growth and has
the least adverse outcomes for the ELBW infant?
Search Terms: human milk, breast milk, formula, term formula, preterm formula,
premature infant, low birth weight infant, very low birth weight infant, extremely low
birth weight infant
Summary of findings:
No RCTs have been done comparing maternal human milk to formula due to the
ethical implications of conducting such a study. A systematic review compared donor
human milk to formula and found those infants fed formula had a higher incidence of
NEC. The AAP Section on Breastfeeding (2005) developed a policy statement for
exclusive human milk feeding of all newborns including premature infants until at least
six months of age.
Table 6: Human Milk
Author/Year

Quigley,
Henderson,
Anthony &
McGuire, 2008

Study Design
Level of Evidence
Systematic
Review

I

Study Purpose/Study Sample
Study Intervention/Study Outcome

Results

Purpose: To determine the effect of
feeding with formula vs. donor
human milk on growth and
development and adverse outcomes in
preterm low birth weight infants

Infants who were fed formula
had higher rates of short term
growth when compared to
infants fed donor human milk.

Sample: 8 RCTs with 1,107 clinically
stable preterm infants born at less
than 32 weeks gestational age.
Intervention: Formula milk feeding
versus donor human milk feeding
Primary Outcomes: short and long
term growth, neurodevelopmental
outcomes at 12months, severe
neurodevelopmental disability,
cognitive and educational outcomes at
more than 5 years of age.
Secondary Outcomes: mortality,
NEC, time to establish full feedings,
feeding intolerance, sepsis.
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Formula feeding was
associated with a higher risk
of developing NEC. No effect
was found on long term
growth or development.

GRADE
Quality of
Evidence
High
Study
Limitations
None

Feeding Route
PICO Question: Should feedings in the ELBW infant be given through an orogastric or
nasogastric feeding tube?
Search Terms: feeding tube, feeding methods orogastric (OG) feedings, nasogastric (NG)
feedings, premature infant, low birth weight infant, very low birth weight infant, and
extremely low birth weight infant
Summary of findings:
One systematic review found insufficient evidence to support the routine use of
nasogastric or orogastric tube feedings in preterm infants.
Table 7: Feeding Route
Author/Year

Hawes, McEwan &
McGuire, 2008

Study Design
Level of Evidence
Systematic
Review

Study Purpose/Study Sample
Study Intervention/Study Outcome
I

Purpose: To determine the effect of
feeding tube placement (nasogastric
(NG) vs. orogastric (OG)) on feeding,
growth and development, and adverse
consequences in preterm or low birth
weight infants.
Sample: 2 RCTs of preterm infants
less than 37 weeks gestational age or
low birth weight infants less than
2,500 grams
Intervention: Enteral feedings given
via NG route versus the OG route
Primary Outcomes: time to establish
full enteral feedings, time to regain
birth weight, growth assessed at
intervals starting at 6 months of age.
Secondary Outcomes: time to
establish full oral feedings, time to
extubation, time to be without oxygen
supplementation, duration of hospital
stay, and adverse events (apnea,
pneumonia, NEC, gastric or
esophageal perforation, nasal
deformities, and neurodevelopmental
outcomes)
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Results

Insufficient evidence to support
routine use of either NG or OG
route for feedings.

GRADE
Quality of
Evidence
High
Study
Limitations
None

Time of feeding administration
PICO Question: Should feedings in the ELBW infant be administered as an intermittent
bolus or as a continuous infusion?
Search terms: feeding methods, continuous, intermittent, enteral nutrition, enteral
feedings, premature infant, low birth weight infant, very low birth weight infant and
extremely low birth weight infant
Summary of findings:
One systematic review found no difference in feeding administration on the
incidence of NEC but insufficient evidence exists to recommend continuous feedings or
intermittent bolus feedings. The American Dietetic Association (ADA) Pediatric
Nutrition Practice Group (2009) points out that continuous feedings may be appropriate
in the ELBW infant who exhibits signs of feeding intolerance or gastroesophageal reflux
(GER).
Table 8: Timing of Feeding Administration
Author/Year
Premji & Chessel,
2011

Study Design
Level of Evidence
Systematic
I
Review

Study Purpose/Study Sample
Study Intervention/Study Outcome
Purpose: To determine the
effectiveness of continuous versus
intermittent gavage feeding as a
feeding strategy in preterm infants
weighing less than 1,500 grams.

No difference was found in
continuous or intermittent
enteral feedings on the time to
reach full enteral feedings
regardless of tube placement.

Sample: 7 RCTs with 511 premature
infants with birth weight less than
1,500 grams

The reports of NEC between the
two methods of feeding were
similar.

Intervention: Continuous enteral
feedings vs. intermittent bolus enteral
feedings

Authors concluded not enough
evidence exists to determine the
best feeding method for preterm
infants with birth weight less
than 1,500 grams.

Primary Outcomes: feeding
intolerance, days to regain birth
weight, age at full enteral feedings,
age at discharge, somatic growth, and
NEC
Secondary Outcome: Apnea
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Results

GRADE Quality
of Evidence
High
Study
Limitations
None

Rate of Feeding Advancement
PICO Question: Should feedings be advanced at a slower or faster rate in order to
promote growth and prevent NEC in the ELBW infant?
Search Terms: feeding advancement, growth, NEC, premature infant, low birth weight
infant, very low birth weight infant, and extremely low birth weight infant.
Summary of findings:
One systematic review determined that the rate of feeding advancement did not
increase the incidence of NEC and increasing feedings at a faster rate of 30-35ml/kg/day
was associated with a decrease in the time to reach full feedings and regain birth weight.
The authors of the systematic review recommended using caution when advancing
feedings at a faster rate in the ELBW infant due to the small number of ELBW infants
included in the systematic review.
Table 9: Rate of Feeding Advancement
Author/Year

Morgan, Young &
McGuire 2011b

Study Design
Level of Evidence
Systematic
Review

I

Study Purpose/Study Sample
Study Intervention/Study Outcome

Results

Purpose: To determine the effect of
slowly advancing enteral feedings on
the incidence of NEC, mortality and
other morbidities in very low birth
weight infants.

Slowly advancing enteral feedings
does not reduce the risk of NEC
but it decreases the amount of
time for an infant to regain their
birth weight and the amount of
time to establish full enteral
feedings.

Sample: 4 RCTs with a total of 496
premature infants less than 32 weeks
gestation and birth weight less than
1,500 grams
Intervention: Advancement of
feedings at a maximum rate of
24ml/kg/day vs. faster advancement
(30-35 ml/kg/day) of feedings
Primary Outcomes: NEC and all
cause mortality during the neonatal
period and prior to hospital discharge
Secondary Outcomes: growth,
neurodevelopment, time to establish
full enteral feeding, feeding
intolerance, infection and length of
stay.
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Length of stay was not affected
by the rate of enteral feeding
advancement.

GRADE
Quality of
Evidence
High
Study
Limitations
None

Human Milk Fortification
PICO Question: Does human milk fortification improve growth in the ELBW infant?
Does fortification with higher amounts of protein improve growth in the ELBW infant?
Search Terms: human milk fortification, growth, enteral protein, protein, protein
fortification, premature infant, low birth weight infant, very low birth weight infant, and
extremely low birth weight infant
Summary of findings:
One systematic review done in preterm infants found that human milk
fortification with a multi-component human milk fortifier is needed to improve growth
and support bone mineralization. Another systematic review found that additional protein
supplementation of 3-4g/kg/day is needed to promote adequate growth in infants
weighing less than 2,500 grams once they are receiving full enteral feedings.
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Table 10: Human Milk Fortification
Author/Year

Kuschel & Harding,
2009

Study Design
Level of Evidence
Systematic
Review

Study Purpose/Study Sample
Study Intervention/Study Outcome
I

Purpose: To determine if human
milk fortification with a multicomponent fortifier improved growth,
bone metabolism and
neurodevelopmental outcomes
without significant adverse effects in
preterm infants.

Results

Human milk fortification improves
short term weight gain, linear and
head growth as well as possible
bone formation without adverse
effects.

GRADE
Quality of
Evidence
High
Study
Limitations
None

No long term benefits of human
milk fortification were found.

Sample:13 RCT with over 600
preterm infants
Intervention: Fortified human milk
feedings vs. non-fortified human milk
feedings during the NICU stay.

Primary Outcomes: growth to
discharge, size at 12-18 months, bone
metabolism, and neurodevelopmental
outcomes

Premji, Fenton &
Sauve, 2010

Systematic
Review

I

Secondary Outcomes: fractures,
nitrogen retention, adverse effects
(hypercalcemia, GI* disturbances,
feeding intolerance, diarrhea, NEC,
blood pH, BUN levels, death).
Purpose: To determine the effect of
higher versus lower protein intakes of
formula fed preterm infants on
growth and neurodevelopment
Sample: 5 RCTs of formula fed
hospitalized infants less than 2,500
grams
Intervention: higher enteral protein
intake v lower enteral protein intake
Primary Outcomes: growth,
nitrogen utilization and accretion, IQ
scores, 18month Bayley Scores,
growth failure, phenylalanine levels
Secondary Outcomes: gastric
motility, days to full feedings,
feeding intolerance, NEC, metabolic
acidosis, serum albumin, sepsis, and
diarrhea.

Note. GI=gastrointestinal
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Increased protein intake (34g/kg/day) improved weight gain by
2g/kg/day, which was associated
with increased lean body mass.
No difference in phenylalanine
levels.
Limited evidence on long term
outcomes and neurodevelopmental
outcomes.

High
Study
Limitations
None

Post Discharge Nutrition
PICO Question: Should the ELBW infant continue to receive fortified human milk after
discharge to improve growth? Should the ELBW infant continue to receive premature
infant formula after discharge to improve growth?
Search Terms: post discharge nutrition, human milk fortification, premature infant
formula, infant nutrition, premature infant, low birth weight infant, very low birth weight
infant, and extremely low birth weight infants.
Summary of findings:
The evidence for post discharge nutrition involves mostly premature infants
without a focus on the ELBW infant. A case control study done in ELBW infants found
an increase their total energy expenditure at discharge when compared to term infants.
Two systematic reviews address post discharge nutrition in the premature infant, less than
37 weeks gestation. One systematic review compared fortified human milk to plain
human milk after discharge and found an improvement in growth but the review was
limited to 1 RCT. A second systematic review compared nutrient enriched premature
infant formula to a standard term infant formula after discharge and determined the use of
a nutrient enriched premature infant formula was not necessary after discharge in infants
who were able to tolerate ad libitum feedings. The AAP Committee on Nutrition (2004)
recommends premature infants especially those born at lower gestational ages receive
fortified human milk or nutrient enriched premature formula until at least 9 months of age
to meet their additional vitamin, mineral and caloric needs to promote adequate catch up
growth.
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Table 11: Post Discharge Nutrition
Author/Year

Guilfoy, WrightColtart, Leitch &
Denne, 2008

Study Design
Level of Evidence
Case Control

IV

Study Purpose/Study Sample
Study Intervention
Study Outcome
Purpose: To determine total
energy expenditure in ELBW
infants at discharge in comparison
to term infants
Sample: 10 ELBW infants on full
feedings for at least 3 weeks and
receiving fortified human milk or
a post-discharge formula, 14
healthy term infants being
breastfed at time of the study
Intervention: Double labeled
water method to determine energy
expenditure

Henderson, Fahey
& McGuire, 2009

Systematic
Review

I

Outcomes: energy expenditure
Purpose: To determine the
effects of nutrient enriched
formula fed after discharge from
the NICU on the preterm infant’s
growth and development
Sample: 7 RCTwith 631 preterm
infants partially fed formula
following discharge from the
NICU.

Results

Total energy expenditure was
significantly higher in the ELBW
infant estimated to be greater than
90kcal/kg/day despite higher energy
intake at about 130kcal/kg/day.

GRADE
Quality of
Evidence
Low
Study
Limitations
None

The ELBW infant had more lean fat
free mass than their term
counterparts.
Correction for fat free mass continued
to show significantly higher energy
expenditure in the ELBW infant.
Weight gain in the ELBW infant was
significantly higher than the healthy
term infant.
Infants fed nutrient enriched formula
ad libitum after discharge from the
NICU had no statistical difference in
growth, neurodevelopment, bone
mineralization or feeding intolerance.

High
Study
Limitations
None

Intervention: Nutrient enriched
formula feedings versus standard
term infant formula feeding.
Primary Outcomes: short and
long term growth,
neurodevelopmental outcomes at
12months of age, severe
neurodevelopmental disability,
and cognitive and educational
outcomes at more than 5 years of
age.

McCormick,
Henderson, Fahey
& McGuire, 2010

Systematic
Review

I

Secondary Outcomes: bone
mineralization, feeding
intolerance, clinical evidence of
rickets, blood pressure readings,
and BMI* at long term follow up.
Purpose: To determine effect of
plain human vs. multi-nutrient
fortified human milk on growth
and development of the premature
infant
Sample: 1 RCT of 39 preterm
infants less than 33 weeks
gestational age
Primary Outcomes: growth
during the study period, long term
growth and growth restriction,
neurodevelopmental outcomes,
and education and cognitive
outcomes at greater than 5 years
of age
Secondary Outcomes: bone
mineralization, feeding
intolerance, duration of breast
feeding, and evidence of rickets,
blood pressure values, and BMI*
at long term follow up.

Note. BMI=body mass index
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Feeding preterm infants with multinutrient fortified human milk
improves growth during infancy but
further trials are needed to confirm
this finding and determine the long
term effects.

High
Study
Limitations
None

Nutrition Assessment
PICO Question: What parameters should be used to monitor growth in the ELBW infant?
What laboratory assessments should be done to monitor the nutritional status of the
ELBW infant? How often should laboratory assessments be done to monitor the
nutritional status of the ELBW infant?
Search Terms: laboratory assessment, nutritional assessment, growth assessment,
premature infant, low birth weight infant, very low birth weight infant, and extremely low
birth weight infant
Summary of findings:
No clinical trials or observational studies have been done to address what
parameters or laboratory data should be used to monitor nutrition in the ELBW infant.
The ADA Pediatric Nutrition Practice Group (2009) provides recommendations for
laboratory assessment of nutrition in premature infants. Moyer-Mileur (2007) provides
recommendations for anthropometric measurements and laboratory assessment for
monitoring nutritional status and growth in infants less than 1,500 grams.
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CHAPTER 3
CONCEPTUAL MODEL
ACE STAR MODEL OF KNOWLEDGE TRANSFORMATION
The ACE Star Model of Knowledge Transformation provides a framework for
understanding the concepts and processes utilized in the implementation and integration
of EBP (Stevens, 2004). This model is a five point star that depicts the five different
stages of knowledge transformation. The stages of knowledge transformation include
discovery, summary, translation, integration and evaluation (Stevens, 2004). Each stage
of knowledge transformation builds upon the previous stage of knowledge leading to
newly discovered knowledge and information that may be used and implemented into
clinical practice.
Discovery
The first stage of knowledge transformation or star point is discovery where new
knowledge is generated (Stevens, 2004). In this stage, knowledge may be gained from
conducting primary research studies or through a review of the literature to determine
best clinical practices. The knowledge generated from either primary research studies or a
literature review may then be used to guide clinical care decisions.
Summary
The second stage of knowledge transformation or star point is summary and is
directly related to the EBP process. In this stage, primary research studies from a
literature review are summarized into a meaningful and concise statement. The summary
of evidence is usually done in the form of a systematic review or meta-analysis (Stevens,
2004). A systematic review or meta-analysis is considered to be the highest level and best
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evidence that should be used to guide clinical practice (Melnyk & Fineout-Overholt,
2010).
Translation
The third stage of knowledge transformation or star point is translation.
Translation is taking the summary of evidence in a systematic review or meta-analysis
and developing a CPG to guide and standardize clinical practice (Stevens, 2004).
Integration
The fourth stage of knowledge transformation or star point is integration where new
knowledge such as a CPG is implemented and used in clinical practice. Integration
involves making and promoting change within the individual and the organization.
Utilizing CPGs based on the highest level and quality of evidence promotes EBP in the
clinical setting and will serve to improve clinical outcomes (Newhouse et al., 2007).
Evaluation
The last stage of knowledge transformation or fifth star point is evaluation.
Evaluation involves assessing the outcome of the EBP change (Stevens, 2004). The
outcomes may include clinical care outcomes, patient satisfaction, system efficiency or
efficacy as well as a cost analysis. This final stage of knowledge transformation is
imperative to the EBP process so that the desired effect or outcome may be evaluated and
further clinical practice improvements can be made.
The ACE Star Model of Knowledge Transformation utilizes a five step process
for understanding knowledge transformation, which can be applied to learning and
implementing EBP. The third and fourth points of the ACE Star Model are the most
congruent with the development and dissemination of this CPG. This guideline was
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developed using the highest level of evidence available to guide neonatal health care
providers in managing the daily nutrition of ELBW infants so that postnatal growth and
neurodevelopment may be improved.
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CHAPTER 4
PROJECT PLAN
ETHICAL CONSIDERATION
This doctoral project was submitted to the University of Nevada Las Vegas
Institutional Review Board in April of 2011. The project was reviewed according to the
federal regulatory statutes 45CFR46 and it was deemed exempt from needing IRB
approval.
THE PROJECT
The EBP process was used in developing this CPG to address the nutritional
management of the ELBW infant. The process included: developing a clinical question
using the PICO format, completing an extensive review of the literature, categorizing the
level of evidence, and evaluating the quality of evidence and strength of
recommendations to be included in the CPG. The PICO questions and specific terms used
to search the literature are included with the review of the literature and resulting
evidence tables located in Chapter 2. Consistent with the conceptual framework for this
project, systematic reviews were used where available.
The level of evidence was rated utilizing the Melnyk & Fine-Overholt (2010)
Rating System for the Hierarchy of Evidence, which is the National Association of
Neonatal Nurses (NANN) preferred model for rating level of evidence when developing a
CPG. The quality of evidence and strength of recommendations were evaluated using the
GRADE System, which meets the IOM’s recommendations for evaluating the quality of
evidence and the strength of recommendations used in developing CPGs.
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EVALUATION
Peer review and evaluation of this CPG will be completed by two NANN
members. The NANN members will be doctorally prepared neonatal nurse practitioners
who have served on the NANN Board of Directors and various other NANN committees.
Each reviewer will be asked to use the NANN Instructions for Writing Clinical Practice
Guidelines to evaluate the CPG for content validity. The peer review period is expected
to take three months and will commence upon successful defense of this doctoral project.
PRODUCT
According to the IOM (2008) CPGs should be developed by expert panels that
have knowledge regarding the clinical situation and have the ability to interpret clinical
research to make sound clinical judgments. The ultimate plan for this doctoral project is
submission for publication, thereby transitioning this project into a product that may
change practice. Pending expert review (described above) and revisions if needed, this
CPG will be submitted to NANN for publication. Neonatal nursing practice is governed
by NANN, who has published several CPGs to guide the clinical management of
critically ill neonates. Therefore, NANN would be the most appropriate site for
publication of this CPG.
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CHAPTER 5
RESULTS
This chapter presents the evidence based recommendations for the nutritional
management of the ELBW infant. The recommendations are included in the table below
and have been organized according to the NANN Guidelines for writing CPGs. The
practice recommendation column includes the guidelines for practice and the rationale or
supporting evidence for each practice guideline. The level of evidence column indicates
the strength of evidence for each guideline and is followed by the GRADE quality of
evidence and strength of recommendation. References in support of the practice
recommendations are included in the reference column.
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Table 12: Practice Recommendations and Rationale
Practice Recommendation
The overall nutritional management of the ELBW
should be based on intrauterine nutrient accretion
rates to promote a weight gain of 15-20g/kg/day.

Level of
Evidence
VII

Quality of
Evidence
Very Low

Strength of
Recommendation
Recommend

Reference
(AAP Committee on
Nutrition, 1985; Ziegler,
O’Donnell, Nelson &
Fomon, 1976)

Rationale: Nutrient accretion rates are considered the
best reference for growth of ELBW infants (AAP
Committee on Nutrition, 1985). The intrauterine rates
of accretion have been determined utilizing published
data on the chemical analysis of the fetus in order to
provide a reference fetus comparable to the
premature infant and the ELBW infant (Ziegler, et.
al, 1976).
Fluid intake will vary depending on the ELBW
infant’s gestational and postnatal age, disease process
and severity of illness. Fluid intake for the ELBW
infant should be restricted to meet the infant’s
physiologic needs.
Rationale: Fluid restriction avoids excess water load
on the immature kidney preventing fluid volume
overload, which is associated with an increased
incidence of NEC and PDA in premature infants.
(Bell& Accareugi, 2010).
Fluid intake for the ELBW infant during the first
week of life should be based on the amount of
insensible water loss and urinary output. Fluid intake
should start at 60-80ml/kg/day on the first day of life
and be advanced by 10-20ml/kg/day throughout the
first week of life to a maximum of 160170ml/kg/day.
Rationale: Fluid management during the first week
of life should allow for contraction of the
extracellular fluid volume resulting in postnatal
diuresis and a10-15% loss of birth weight. Failure to
strictly manage fluid intake at such a critical time has
been shown to increase the incidence of PDA and
BPD in the ELBW infant (Oh et al., 2005; Stephens
et al, 2008).
The ELBW infant should be placed in a double
walled isolette with ambient humidity of 70%-80% to
aid in insensible water loss and fluid and electrolyte
balance.
Rationale: The ELBW infant is born with an
immature non-keratinized epidermis resulting in
insensible water loss through the immature skin layer.
In two retrospective cohort studies, placement of
ELBW infants in humidity was found to decrease
total fluid intake, improved electrolyte balance and
improve growth (Gaylord, et al., 2001; Kim, et al.,
2010).
After the first week of life when postnatal diuresis is
complete, the goal of fluid management should shift
from replacing water loss to providing enough
nutrients for adequate growth. The target fluid goal
for promoting adequate growth should be:

Fluid & Electrolyte Management
I
High

Strongly
Recommend

(Bell & Accareugi, 2010)

IV

Low

Recommend

(Oh et al., 2005; Stephens
et al., 2008)

IV

Low

Recommend

(Gaylord, et al., 2001; Kim,
et al., 2010).

VII

Very Low

Recommend

(AAP Committee on
Nutrition, 2004; Adamkin,
2009)

140-160ml/kg/day and may be adjusted in 1020ml/kg/day increments until reaching the fluid goal.
Rationale: Adequate fluid intake after postnatal
diuresis is essential for adequate nutrient intake and
postnatal growth. The recommended fluid intake
promotes weight gain consistent with intrauterine
values (AAP Committee on Nutrition, 2004).
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Sodium should be withheld during the first 5 days of
life to promote postnatal diuresis. After diuresis, a
recommended daily intake of sodium at 23meq/kg/day should be sufficient to meet the daily
needs of the ELBW infant.
Rationale: Sodium restriction during the first 5 days
of age results in contraction of the extracellular fluid
volume promoting postnatal diuresis (Shaffer &
Meade, 1989). Infants who were supplemented with
sodium within the first 5 days of life developed
hypernatremia, required higher fluid intakes, and had
a higher incidence of BPD (Costarino, et al., 1992).
Potassium should be held during the first 5 days of
life until postnatal diuresis is complete. An intake of
2-3meq/kg/day is recommended to the meet the daily
needs of the ELBW infant.

II

Moderate

VII

Very Low

IV

Low

VII

Very Low

Strongly
Recommend

(AAP Committee on
Nutrition, 2004)

Recommend

The recommended intake for calcium, phosphorus,
and magnesium increases once the ELBW infant is
on full enteral feedings. Calcium intake should be
100-200mg/kg/day. Phosphorus intake should be 60140mg/kg/day. Magnesium intake should be 7.915mg/kg/day.

Mineral Requirements
II
High

(Lorenz et al., 1997)
(AAP Committee on
Nutrition, 2004; ADA
Pediatric Nutrition Group,
2009)

Rationale: The ELBW infant is at risk for
developing non-oliguric hyperkalemia due to
intracellular shifts in potassium during the first 5 days
of life requiring potassium to be held (Lorenz et. al,
1997).
Calcium, phosphorus, and magnesium should be
administered at a rate that mimics intrauterine
accretion. Calcium intake should be 60-90mg/kg/day,
phosphorus intake should be 47-70mg/kg/day, and
magnesium intake should be 4.3-7.2mg/kg/day when
receiving parenteral nutrition. Calcium and
phosphorus should be administered in a 1:1 molar
ratio.

(Costarino et al., 1992;
Shaffer & Meade, 1989)

Strongly
Recommend

(Prestridge et al., 1993)

VII

Very Low

(AAP Committee on
Nutrition, 2004)

VII

Very Low

(ADA Pediatric Nutrition
Practice Group, 2009)

Rationale: Administering calcium, phosphorus, and
magnesium to mimic intrauterine accretion rates
improves bone mineral content decreasing the
incidence of osteopenia of prematurity. In a RCT,
administering higher doses of calcium and
phosphorus within the first few days of life improved
serum concentrations of phosphorus and bone
mineral content from 1 week to 26 weeks
postconceptual age (Prestridge et al., 1993).
Caloric intake for the ELBW infant should be
supplied at the same intrauterine rate to promote
optimal growth. Total caloric intake should be based
on maintaining an energy balance of 2530kcal/kg/day, which is estimated to be:
80kcal/kg/day to maintain body energy stores while
receiving parenteral nutrition and should be the goal
immediately after birth and within the first few days
of life.

Energy Requirement
II
Moderate
VI

Low

VII

Very Low

105-115kcal/kg/day (including 3.5g/kg/day of amino
acids) to promote growth while receiving parenteral
nutrition.
130-150kcal/kg/day to promote growth while
receiving full enteral nutrition, additional protein may
be needed to accompany the higher caloric intake.
Rationale: Energy expenditure in the ELBW infant
is estimated to be higher than the currently
established values that are based on growing healthy
premature infants (Carr, et al., 2000) Supplying
additional calories along with an increased amount of
protein has been shown to improve nitrogen retention
leading to improved growth (Zlotkin, 1981).
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Recommend

(Zlotkin et al., 1981)
(Carr et al., 2000)
(Leitch & Denne, 2005;
Hay, 2005)

Glucose intake for the ELBW infant shall be supplied
at the same intrauterine rate to maintain adequate
energy supply and should be administered directly
after birth. Glucose infusion should start at:

Glucose Management
I
High
VII

Very Low

I

High

Recommend

(Sinclair et al., 2011)
(AAP Committee on
Nutrition, 2004; Hay,
2005)

5-7mg/kg/min and be advanced as tolerated by 12mg/kg/min to a maximum of 10-11mg/kg/day when
receiving full parenteral nutrition.
Rationale Glucose is the major source of energy for
the fetal brain and is required to ensure adequate
energy supply to the ELBW infant’s brain.
Insufficient evidence exists to determine the exact
rate of glucose utilization but experts suggest using
the fetal rate of glucose utilization as a guide for
administering glucose to the ELBW infant (Hay,
2005; Sinclair et al., 2011).
In the ELBW infant hyperglycemia occurs frequently
during the first week of life due to glucose
administration. Treatment of hyperglycemia may
involve decreasing the glucose infusion rate or
administering an insulin infusion but insulin should
not be given to prevent hyperglycemia in the ELBW
infant.

Strongly Recommend

(Bottino et al., 2011;
Sinclair et al., 2011)

Strongly
Recommend

(Ibrahim et al., 2004;
Wilson et al., 1997)

Strongly
Recommend

(Anderson et al., 1979;
Blanco et al., 2011; Clark
et al., 2007; Murdock et al.,
1995;; Poindexter et al.,
2006; Rivera et al., 1993;
TeBraake et al., 2005;
Thureen et al., 2003; Van
Goudoever et al., 1995;
Van Lingen et al., 1992;)

Rationale: The exact cause of hyperglycemia seen in
the ELBW during the first few days of life is still
unknown but it is thought to be a result of glucose
intolerance. Insufficient evidence exists to determine
the exact method for treatment of hyperglycemia but
insulin infusion to prevent hyperglycemia was found
to be associated with an increase in death before 28
days of age (Bottino et al., 2011; Sinclair et al.,
2011.)
Early aggressive nutrition should be administered to
the ELBW infant. The nutritional plan should include
early administration of amino acids, intralipids and
minimal enteral feedings (MEF).
Rationale: An early aggressive nutrition plan
improves caloric intake within the first week of life
and promotes nitrogen balance (Ibrahim et al., 2004;
Wilson et al., 1997). In a RCT, a nutrition plan that
included early administration of amino acids,
intralipids and MEF was shown to improve weight,
length and head circumference of infants less than
1,500 grams at discharge (Wilson, et al., 1997).
Amino acids should start right after birth at a rate of
3g/kg/day and should be increased by 0.5-1g/kg/day
until reaching a maximum of 4g/kg/day.

Early Aggressive Nutrition
II
Moderate

II

Moderate

Rationale: Protein administration improves plasma
amino acid levels, which promotes protein synthesis
(Anderson, et. al, 1979; Blanco et al., 2011; Clark et
al., 2007; Murdock et al., 1995; Rivera et al., 1993;
TeBraake et al., 2005; Van Goudoever et al., 1995
Van Lingen et al., 1992) Giving protein at 3g/kg/day
is considered to be safe and mimics protein accretion
rates seen in-utero as well as improves glucose
tolerance (Thureen et al., 2003). Administering
protein right after birth is safe and effective in
preventing catabolism, promoting nitrogen and
protein balance without increasing blood urea
nitrogen (BUN) levels or disrupting acid base balance
(Anderson et al., 1979; Rivera et al., 1993; TeBraake
et al., 2005; Thureen et al., 2003; Van Goudoever et
al., 1995; Van Lingen et al., 1992). The early
administration of protein to ELBW infants has been
shown to improve weight, length, and head
circumference at 36 weeks postconceptual age
(Poindexter et al., 2006).
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Intralipids should start within 24 hours after birth at a
rate of 0.5-1g/kg/day and should be increased by 0.51g/kg/day until reaching a maximum of 3g/kg/day.
Intralipids should be given continuously over 24
hours.
Rationale: The administration of intralipids prevents
essential fatty acid deficiency and improves glucose
tolerance (Anderson, et al., 1979; Murdock et al.,
1995). In a systematic review, early administration of
intralipids was determined to be safe and have no
adverse effects but could not be recommended for
short term growth (Simmer & Rao, 2009). In a RCT,
intralipids given as part of an early aggressive
nutrition plan was found to improve growth of infants
less than 1,500 grams within the first week of life and
at hospital discharge (Wilson, et al., 1997).
Minimal enteral feedings (MEF) should be started
within the first 1 to 4 days of age at a rate of 1025ml/kg/day. Minimal enteral feedings should be
given for at least 5 to 7 days.

I

High

II

Moderate

I

High

II

High

I

Enteral Nutrition
High

Strongly
Recommend

(Simmer & Rao, 2009)
(Anderson et al., 1979;
Murdock et al., 1995;
Wilson et al., 1997)

Strongly
Recommend

(Bombell & McGuire,
2009; Morgan et al.,
2011a)
(Wilson et al., 1997)

Rationale: In a RCT, MEF when given as part of an
early aggressive nutrition plan was found to improve
enteral intake and feeding tolerance without
increasing the incidence of NEC (Wilson, et al.,
1997). Introducing MEF early within the first few
days of life is further supported by two systematic
reviews that found delaying feedings and the use of
trophic feedings had no significant effect on the
incidence of NEC (Bombell & McGuire, 2009;
Morgan et al., 2011a).
Human milk should be used for enteral feedings in
the ELBW infant. Donor human milk should be used
when maternal human milk is unavailable or is
contraindicated. In cases where human milk
(maternal or donor) is unavailable a premature infant
formula may be used for enteral feedings but the use
of formula should not be the feeding of choice.
Rationale: Human milk is species specific and all
other formula preparations are substantially different
making human milk uniquely superior for infant
feeding (AAP Section on Breastfeeding, 2005).
Human milk contains immunoprotective and growth
factors that protect the immature gut mucosa of the
ELBW infant. Infants fed formula instead of human
milk (maternal or donor) are have an increased risk
for developing NEC (Quigley et al., 2008).
Enteral feedings may be administered through an oral
or nasal gastric feeding tube.
Rationale: The ELBW infant is not able to
coordinate sucking and swallowing needed for oral
nipple feedings placing them at high risk for
aspiration. In addition, the ELBW infant’s immaturity
and severity of illness prevents them from being able
to tolerate nipple feedings, which requires enteral
feedings to be administered via a feeding tube.
Evidence is lacking to support the routine placement
of feeding tubes in the nose or mouth (Hawes et al.,
2008). However, infants are obligate nose breathers
and placing a feeding tube into their nares may lead
to partial obstruction, increased airway resistance and
increased work of breathing (Hawes et al., 2008).
Enteral feedings may be given every 2-3 hours as an
intermittent bolus or continuously via a feeding
pump.

Strongly
Recommend

(Quigley et al., 2008)

VII

Very Low

I

High

Strongly
Recommend

(Hawes et al., 2008)

I

High

Strongly
Recommend

(Premji & Chessell, 2011)

VII

Very Low

Rationale: Insufficient evidence exists to determine
the best feeding method for the ELBW infant. In a
systematic review no difference in the incidence of
NEC or time to reach full feedings was found
between intermittent or bolus feedings (Premji &
Chessell, 2011). Continuous feedings may be
warranted in ELBW infants with feeding intolerance
or those with symptoms of gastroesophageal reflux
(ADA Pediatric Nutrition Practice Group, 2009).

52

(AAP Section on
Breastfeeding, 2005)

(ADA Pediatric Nutrition
Practice Group, 2009)

Advancement of enteral feedings should take into
consideration the ELBW infant’s gestational age and
severity of illness. Enteral feedings may be advanced
by 20-35ml/kg/day as tolerated until reaching full
fluid intake at 140-160ml/kg/day.
Rationale: Current evidence is lacking on the
feeding advancement for the ELBW infant. In a
systematic review, the rate of feeding advancement
was not associated with an increased risk for NEC
and slow advancement of feedings prolonged the
need for parenteral nutrition and the time to regain
birth weight in infants weighing less than 1,500
grams (Morgan et al., 2011b).
Human milk (maternal or donor) should be fortified
with commercially available human milk fortifiers.
Fortification of human milk should be done gradually
to prevent feeding intolerance and may begin with
22kcal/ounce when the infant is tolerating
100ml/kg/day of enteral feedings and advanced as
tolerated to 24kcal/ounce when the infant is tolerating
full enteral feedings at 140-160cc/kg. If human milk
is unavailable, the infant may be given a premature
formula and should be advanced to 24kcal/ounce
premature formula in the same manner as the infant
receiving human milk.

I

High

Strongly
Recommend

(Morgan et al., 2011b)

I

High

Strongly
Recommend

(Kuschel & Harding, 2009)

VII

Very Low

I

High

(Adamkin, 2009; ADA
Pediatric Nutrition Practice
Group, 2009)

Rationale: The composition of human milk varies
from person to person with protein, fat, and mineral
content decreasing throughout lactation. The
reduction of protein, fat and minerals in human milk
fails to meet the nutritional needs of the ELBW
infant. Fortifying human milk with commercial
human milk fortifiers provides the additional amount
of energy and protein needed for growth while
providing adequate amounts of calcium and
phosphorus to improve bone mineral content in the
ELBW infant (Kuschel & Harding, 2009).
The addition of human milk fortifiers increases the
osmolality of the human milk and may result in
feeding intolerance (ADA Pediatric Nutrition
Practice Group, 2009). Although human milk
fortification is not associated with an increased risk
of NEC (Kuschel & Harding, 2009) utilizing a step
wise approach will help to prevent feeding
intolerance and the need to stop feedings or decrease
enteral intake.
In addition to human milk fortification, enteral
feedings should be supplemented with extra protein
to reach a daily requirement of 3-4g/kg/day. If human
milk is unavailable a premature infant formula with
additional protein may be used.
Rationale: The intrauterine accretion rate of protein
to promote adequate growth is estimated to be 34g/kg/day. In a systematic review, protein
supplementation of enteral feedings at intrauterine
accretion rates was found to improve nitrogen
balance and promote weight gain in infants less than
2,500 grams (Premji, et al., 2010).
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Strongly
Recommend

(Premji, et al., 2010)

The ELBW infant should continue to receive fortified
human milk after discharge to meet their high energy
needs and to promote growth. In cases where human
milk is unavailable the ELBW infant should continue
to receive a premature infant formula after discharge.

Post Discharge Nutrition
I
High

Strongly
Recommend

(Henderson, et al., 2009;
McCormick et al., 2010)

IV

Low

(Guilfoy et al., 2008)

VII

Very Low

(AAP Committee on
Nutrition, 2004)

The amount of human milk fortification or caloric
density of the premature infant formula should be
adjusted to 22kcal/ounce just prior to discharge. The
need for additional fortification should be based on
the ELBW infant’s disease process, weight gain, and
history of osteopenia of prematurity.
Rationale: The exact nutrient requirements for the
ELBW infant have yet to be determined but it is clear
that the ELBW infant continues to have a high energy
need at time of discharge that must be met (Guilfoy,
et. al, 2008). A systematic review of 1 RCT showed
improvement in growth of premature infants fed
fortified human milk upon discharge (McCormick, et
al., 2010) In another systematic review, premature
infants able to tolerate ad libitum feedings did not
need a premature infant formula at discharge
(Henderson et al., 2009). According to the AAP
Committee on Nutrition (2004) human milk
fortification or the use of premature infant formula
should continue until at least 9 months of age to meet
the additional vitamin, mineral, and caloric needs of
infants born prematurely.
Anthropometric measurements are used to monitor
growth in all infants and should be done on a routine
basis to monitor growth in the ELBW infant.

Nutritional Assessment
VII
Very Low

Weight should be measured daily with use of a bed
scale if possible due to the critical nature of the
ELBW infant’s illness. Weight gain should mimic the
intrauterine growth rate of 15-20g/kg/day.

Head Circumference should be measured weekly at
the largest frontal occipital plan. Head circumference
should increase by 0.9cm/week.
Length should measured weekly using a recumbent
length board to obtain the best measurement. Length
should increase by 0.9cm/week.
Rationale: Body weight is representative of total
body mass and is reflective of changes in body
composition to include lean tissue, fat, and the
intracellular and extracellular fluid compartments
(Moyer-Mileur, 2007). Head growth during infancy
correlates well with overall growth and may indicate
poor neurodevelopment if measurements are
abnormal (Moyer-Mileur, 2007). Length is more
closely associated with lean mass and is a better
indicator of long term growth.

54

Recommend

(ADA Pediatric Nutrition
Practice Group, 2009;
Moyer-Mileur, 2007)

Laboratory data may be used to further assess the
nutritional status of the ELBW infant.
Recommendations for laboratory monitoring while
receiving parenteral nutrition are as follows:

VII

Very Low

Recommend

(ADA Pediatric Nutrition
Practice Group, 2009;
Moyer-Mileur, 2007)

VII

Very Low

Recommend

(ADA Pediatric Nutrition
Practice Group, 2009;
Moyer-Mileur, 2007)

Serum glucose should be monitored as needed based
on severity of illness and disease process. Urine
glucose should be monitored 1-3 times a day upon
initiation of parenteral nutrition and then as needed
once stable.
Electrolytes and acid-base balance should be
monitored daily upon initiation of parenteral nutrition
and continue until energy and nutrient needs are met
and stabilized. Once requirements are stable
electrolytes may be monitored every 1-2 weeks as
needed. Acid-base balance may be monitored as
needed.
Calcium, phosphorus, and magnesium should be
monitored a 2-3 times a week during the initiation of
parenteral nutrition and then every 1-2 weeks as
needed.
Triglycerides should be monitored with every rate
increase and then every 1-2 weeks as needed while
receiving intralipids.
Blood urea nitrogen (BUN) and creatinine should be
monitored a 2-3 times a week during the initiation of
parenteral nutrition and then every 1-2 weeks as
needed.
Serum protein levels, liver enzymes, alkaline
phosphatase, and blood cell count should be done to
obtain a baseline at the start of parenteral nutrition
and then every 2-3 weeks as needed.
Rationale: Monitoring laboratory data on a regular
basis during the initiation and continued use of
parenteral nutrition aides allows the healthcare
provider to assess the ELBW infant’s response to
parenteral nutrition and to identify any metabolic
complications that may occur from the use of
parenteral nutrition (Moyer-Mileur, 2007).
Recommendations for laboratory monitoring while
receiving enteral nutrition are as follows:
A baseline evaluation of serum and urine glucose,
electrolytes, acid-base status, BUN, creatinine,
calcium, phosphorus, magnesium, serum protein
levels, liver enzymes, alkaline phosphatase, and
blood cell count should be done upon reaching full
enteral nutrition.
Once the ELBW infant is stable on full enteral
feedings with adequate nutrient and energy intake the
laboratory assessment of electrolytes, calcium,
phosphorus, BUN, creatinine, serum protein levels,
liver enzymes, blood cell count may be done every 23 weeks and adjusted as needed based on clinical
condition.
Rationale: A routine monitoring schedule is not
indicated when infants weighing less than 1,500
grams are clinically stable and receiving adequate
nutrition (Moyer-Mileur, 2007). The
recommendations can be used to monitor nutritional
status and adjusted as needed based on the clinical
condition of the ELBW infant.
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CHAPTER 6
DISCUSSION and IMPLICATIONS for PRACTICE
The aim of this CPG is to provide evidence based practice recommendations on
the nutritional management of the ELBW infant in order to promote adequate
extrauterine growth and prevent or at least decrease EUGR. The need for improving
EUGR in the ELBW infant has been well documented throughout the neonatal literature
(Carroll, Slobodzian & Steward, 2005; Clark et al., 2003; Coverston & Schwartz, 2005;
Yu, 2005) However, research to define the exact nutrient requirements needed to
promote adequate extrauterine growth in the ELBW infant is limited.
Current nutritional management of the ELBW infant focuses on providing
nutrition to promote weight gain that is similar to the intrauterine rate of 15-20g/kg/day,
which has been recommended by the AAP (1985) as the gold standard for premature
infant growth. In order to meet the AAP recommendations, ELBW infants have been fed
diets high in fat and carbohydrates (Hay, 2006). This type of nutritional management has
resulted in large protein and energy deficits that lead to poor extrauterine growth and
EUGR in the ELBW infant (Clark et al., 2003; Stephens et al., 2009).
Strong evidence exists for providing early aggressive nutrition to prevent the
protein and energy deficits that occur in the ELBW infant (Ibrahim et al., 2004; Wilson,
et al., 1997). Most of the research has focused on early administration of amino acids
with a number of the studies being conducted in infants less than 1,500 grams. However,
the few studies conducted in ELBW infants have consistently shown that early
administration of amino acids prevents catabolism, promotes protein synthesis and
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establishes a positive nitrogen balance without adverse effects (Rivera et al., 1993;
TeBraake et al., 2005; Thureen et al., 2003; Van Goudoever et al., 1995).
Energy requirements for the ELBW infant are still unclear and have been largely
estimated from data obtained in healthy growing premature infants (Carr et al., 2000).
Energy intake for the ELBW infant when receiving early amino acids has been estimated
at 70-115kcal/kg/day (Carr et al., 2000; Hay, 2005; Leitch & Denne, 2005; Zlotkin et al.,
1981) However, providing enough energy from non-protein sources is complicated by
hyperglycemia and glucose intolerance in the ELBW infant (Hay, 2006). Administering
intralipids in small doses along with amino acids has been shown to improve glucose
tolerance (Anderson, et al., 1979; Murdock et al., 1995; Rivera et al., 1993; Thureen et
al., 2003). Although early administration of intralipids has no adverse effects, the
evidence to support its use to promote short term growth is conflicting (Simmer & Rao,
2009; Wilson et al., 1997).
Early administration of amino acids and intralipids are not the only components
that make up an early aggressive nutrition plan. Trophic feedings or MEF have been
shown to improve feeding tolerance and later feeding advancement (Wilson et al., 1997).
In addition, the use of MEF has been shown in two systematic reviews to have no effect
on the incidence of NEC (Bombell & McGuire, 2009; Morgan et al., 2011a). However,
clinicians are still withholding feedings due to the fear of NEC (Adamkin, 2005,
Ehrenkranz, 2007).
The exact pathogenesis of NEC is unknown but certain factors have been
associated with its development (Neu, 2008). One of these factors is the commencement
of enteral feedings thought to serve as a substrate for infectious organisms to multiply
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(Lee & Jain, 2000). The use of formula has been shown to increase the incidence of NEC
while human milk has been shown to decrease its incidence (Quigley et al., 2008).
Despite this evidence to support exclusive human milk feeding and the recent
advancements in providing donor human milk ELBW infants are still receiving
premature infant formula as the feeding of choice.
It has been recognized that exclusive human milk feeding over time will not meet
the nutritional needs of the ELBW infant (AAP Committee on Nutrition, 2004).
Fortification of human milk with human milk fortifiers provides the additional nutrients
needed to promote growth and bone mineralization in premature infants (Kuschel &
Harding, 2009). However, continuing such fortification upon discharge is controversial.
One systematic review suggests fortified human milk promotes growth after discharge
but the review only included 1 RCT (McCormick et al., 2010) In another systematic
review the use of a nutrient enriched premature formula after discharge had no effect on
growth when compared to a standard term formula, but these findings were limited to
infants who could tolerate ad libitum feedings (Henderson et al., 2009). Yet, the AAP
(2004) recommends human milk fortification or a premature infant formula to meet the
additional vitamin, mineral and caloric needs of the premature infant. Furthermore,
Guilfoy et al. (2008) found that ELBW infants continued to have high energy expenditure
at the time of discharge despite higher caloric intake of 130kcal/kg/day.
Determining the appropriate post-discharge nutritional regimen for the ELBW
infant is an area needing further investigation. Especially when current evidence suggests
additional protein supplementation of enteral feedings at 3-4g/kg/day is needed to
promote weight gain in infants less than 2,500 grams (Premji et al., 2010). Bhatia (2005)
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suggests that until optimal nutrition regimens are developed growth assessments need to
be done at regular intervals with close attention to growth failure as well as growth
excess.
Regular growth assessments are essential in the ELBW infant not only after
discharge but throughout their NICU stay. Anthropometric measurements have been
standardized in neonatal care whereas laboratory assessment varies depending on each
NICU and healthcare provider. This variation in practice is most likely due to a lack of
evidence to support how often laboratory assessments should be done (Moyer-Mileur,
2009). It is unlikely that a RCT will be done to provide strong evidence for routine
laboratory assessments but observational or cohort studies to determine how often certain
laboratory tests should be done would aid in the nutritional assessment of the ELBW
infant.
Nutritional management of the ELBW infant is not an easy task and is further
complicated by a lack of research done solely in this population of infants. Although,
research done in the VLBW (less than 1,500 grams) infant may be applied to the care of
ELBW infants their extreme prematurity and organ development must still be considered
when providing such care. Therefore, this guideline should not be used without the
careful examination of the ELBW infant’s clinical condition and severity of illness.
IMPLICATIONS FOR PRACTICE
The development of this CPG provides neonatal healthcare providers with
evidence based recommendations on the nutritional management of the ELBW infant and
fulfills an existing gap in neonatal practice. The recommendations in the CPG are
centered on improving extrauterine growth and therefore preventing or at least decreasing
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EUGR. The publication and endorsement of this guideline by NANN will help to
standardize nutritional management of the ELBW infant across the country and
potentially improve growth and outcomes nationwide.
This guideline is the first evidence based CPG addressing the nutritional
management of the ELBW infant. A lack of research done exclusively in the ELBW
infant population has been highlighted with the development of this CPG. Strong
evidence exists for the early administration of amino acids, intralipids and MEF or
trophic feedings to prevent protein and energy deficits that lead to EUGR but maintaining
growth with enteral nutrition is less clear especially after the ELBW infant is discharged
from the NICU. Therefore, further studies are still needed to determine the nutrient
requirements for maintaining adequate extrauterine growth of the ELBW infant.
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